{
  "doc_id": "fellowtpn_revised_07_08_2022v2_joanna_edits_cbedit__65dbcc",
  "original_filename": "fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit.pdf",
  "md_path": "data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit.md",
  "rmd_path": "data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit.rmd",
  "blocks": [
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition (PN) Overview",
      "line": 0
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition (PN) Overview",
      "line": 2,
      "preview": "Dr. John Kerner, MD<br>Joanna Cheung, PharmD, BCNSP, CNSC"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition (PN) Overview",
      "line": 4,
      "preview": "Noon Conference: July 8, 2022"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition (PN) Overview",
      "line": 6,
      "preview": "--- page 1 ---"
    },
    {
      "type": "image",
      "section": "Parenteral Nutrition (PN) Overview",
      "line": 8,
      "content": "![img-0.jpeg](images/324b4d09d82fd0bd.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "2018",
      "line": 10
    },
    {
      "type": "text",
      "section": "2018",
      "line": 12,
      "preview": "--- page 2 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ENTERAL \\& PARENTERAL NUTRITION",
      "line": 14
    },
    {
      "type": "text",
      "section": "ENTERAL \\& PARENTERAL NUTRITION",
      "line": 16,
      "preview": "--- page 3 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "HOME PARENTERA NUTRITION",
      "line": 18
    },
    {
      "type": "text",
      "section": "HOME PARENTERA NUTRITION",
      "line": 20,
      "preview": "--- page 4 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN Process",
      "line": 22
    },
    {
      "type": "image",
      "section": "PN Process",
      "line": 24,
      "content": "![img-1.jpeg](images/73c8a4bb07b608cf.png)"
    },
    {
      "type": "text",
      "section": "PN Process",
      "line": 26,
      "preview": "- **Orders entered by 2:00 PM**"
    },
    {
      "type": "text",
      "section": "PN Process",
      "line": 28,
      "preview": "- **CPOE** \u2192 **Pharmacist Verification** \u2192 **Technician Compound**"
    },
    {
      "type": "text",
      "section": "PN Process",
      "line": 30,
      "preview": "- **Tube/Delivery** \u2192 \u2192 **Nurse Administration**"
    },
    {
      "type": "image",
      "section": "PN Process",
      "line": 32,
      "content": "![img-2.jpeg](images/870d0b8684935159.png)"
    },
    {
      "type": "text",
      "section": "PN Process",
      "line": 34,
      "preview": "--- page 5 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN Process",
      "line": 36
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Web Resources",
      "line": 38
    },
    {
      "type": "image",
      "section": "Web Resources",
      "line": 40,
      "content": "![img-3.jpeg](images/f013cf8fcfade536.png)"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Ingredients:",
      "line": 42
    },
    {
      "type": "text",
      "section": "Ingredients:",
      "line": 43,
      "preview": "- **Bedside Monitor**"
    },
    {
      "type": "text",
      "section": "Ingredients:",
      "line": 44,
      "preview": "- **Cardiac Cath Images**"
    },
    {
      "type": "text",
      "section": "Ingredients:",
      "line": 45,
      "preview": "- **Clinical Pathways**"
    },
    {
      "type": "text",
      "section": "Ingredients:",
      "line": 46,
      "preview": "- **Echocardiology PACS**"
    },
    {
      "type": "text",
      "section": "Ingredients:",
      "line": 47,
      "preview": "- **Infusion Studio**"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Inclusion Studio",
      "line": 49
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 50,
      "preview": "- **Total Parenteral Nutrition**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 51,
      "preview": "- **Enter your User ID and Password:**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 52,
      "preview": "- **User ID:**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 53,
      "preview": "- **Password:**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 54,
      "preview": "- **Sign In:**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 55,
      "preview": "- **Cancel**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 57,
      "preview": "**Stanford Children's Health**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 58,
      "preview": "**Lucile Packard**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 59,
      "preview": "**Children's Hospital**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 60,
      "preview": "**Stanford**"
    },
    {
      "type": "text",
      "section": "Inclusion Studio",
      "line": 62,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 1: Find Patient",
      "line": 64
    },
    {
      "type": "image",
      "section": "Step 1: Find Patient",
      "line": 66,
      "content": "![img-4.jpeg](images/599bd64014fbc67c.png)"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 68,
      "preview": "|  Protocol Select | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 69,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 70,
      "preview": "|  Neonatal Protocol: NICU/PICN/WBN/SEQN | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 71,
      "preview": "|  Pediatric Protocol: PICU, CVICU, 3rd floor, F1/F2 | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 72,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 73,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 74,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 75,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 76,
      "preview": "|  Close | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 77,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 78,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 79,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 80,
      "preview": "|  Current Active Protocol | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 81,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 82,
      "preview": "|  Lucile Salter Packard Children's Hospital: PEDIATRIC | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 83,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 84,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 85,
      "preview": "|  Change Protocol | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 86,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 87,
      "preview": "|  Select Patient | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 88,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 89,
      "preview": "|  Enter patient CSN Number and press the Enter Key | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 90,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 91,
      "preview": "|  Enter CSN Number: | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 92,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 93,
      "preview": "|  Enter Medical Record Number: | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 94,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 95,
      "preview": "|  Patient Information | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 96,
      "preview": "|  Last Name: | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 97,
      "preview": "|  First Name: | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 98,
      "preview": "|  Middle Name: | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 99,
      "preview": "|  Birth Date: 1/1/1904 (M/D/Y) | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 100,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 101,
      "preview": "|  Gender: \u2611 Male \u2610 Female | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 102,
      "preview": "|  Ward: Select Ward: | |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 103,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 104,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 105,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 106,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 107,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 108,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 109,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 110,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 111,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 112,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 113,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 114,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 115,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 116,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 117,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 118,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 119,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 120,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 121,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 122,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 123,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 124,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 125,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 126,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 127,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 128,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 129,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 130,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 131,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 132,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 133,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 134,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 135,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 136,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 137,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 138,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 139,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 140,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 141,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 142,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 143,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 144,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 145,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 146,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 147,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 148,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 149,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 150,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 151,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 152,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 153,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 154,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 155,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 156,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 157,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 158,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 159,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 160,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 161,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 162,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 163,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 164,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 165,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 166,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 167,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 168,
      "preview": "|  |"
    },
    {
      "type": "table",
      "section": "Step 1: Find Patient",
      "line": 169,
      "preview": "|"
    },
    {
      "type": "text",
      "section": "Step 1: Find Patient",
      "line": 171,
      "preview": "--- page 7 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 2: Fluids & Macros",
      "line": 173
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 175
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 177,
      "preview": "**Order Date:** 6/1/2015"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 179,
      "preview": "**Date Due:** 6/1/2015"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 181,
      "preview": "**Weight (kg)**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 183,
      "preview": "**Pen Access Method:** - [ ] PERIPHAN or - [ ] CENTRAL TPN LINE"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 185,
      "preview": "**Total Fluid Intake:** 100 mls/kg"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 187,
      "preview": "**FAT EMULSION:** 1 gm/kg to run over 24 hours, 10 Kcal/kg, 5 mls/kg and 40 mls/day"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 189,
      "preview": "**IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the"
    },
    {
      "type": "table",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 191,
      "preview": "|  |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 192,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 193,
      "preview": "|  Additive | Additive |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 194,
      "preview": "|  Additive |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 195,
      "preview": "|  Additive |  |   |"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 197,
      "preview": "**IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE, complete the followi"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 199,
      "preview": "- [ ] Enteral Feeding"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 200,
      "preview": "- Feeding volume of 1 mls every 2 weeks of 1"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 201,
      "preview": "- Strength Breast Milk/MBM"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 202,
      "preview": "- GIR Value"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 204,
      "preview": "**AMINO ACIDS:** 2 gm/kg Aminosyn 10% provides 8 Kcal/kg, concentration of 2.1%"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 206,
      "preview": "**DEXTROSE:** 10 provides 32.3 Kcal/kg and 6 mg/kg/min glucose (rec range: [6 - 14] mg/kg/min)"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 208,
      "preview": "**Osm: Amino Acids, Dextrose:** 700.8 mOsm/L"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 210,
      "preview": "**Osm: Amino Acids, Dextrose:** 700.8 mOsm/L"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 212,
      "preview": "**<< Previous Step**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 214,
      "preview": "**View Recommendations and Guidelines**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 216,
      "preview": "**View Serum Chemistry**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 218,
      "preview": "**Next Step >>**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 220,
      "preview": "**Stanford Medicine**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 222,
      "preview": "**Stanford**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 224,
      "preview": "**Stanford**"
    },
    {
      "type": "text",
      "section": "Step 2: Route of Administration / Fluid Management / Macronutrients",
      "line": 226,
      "preview": "--- page 8 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 2: Fluids & Macros",
      "line": 228
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Weight (kg)",
      "line": 230
    },
    {
      "type": "text",
      "section": "Weight (kg)",
      "line": 232,
      "preview": "- **PN Access Method:** \u2610 PERIPHERAL or \u2610 CENTRAL TPN LINE"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Total Fluid Intake:",
      "line": 234
    },
    {
      "type": "text",
      "section": "Total Fluid Intake:",
      "line": 235,
      "preview": "- mls/kg"
    },
    {
      "type": "text",
      "section": "Total Fluid Intake:",
      "line": 236,
      "preview": "- Overall Volume: 40 mls"
    },
    {
      "type": "text",
      "section": "Total Fluid Intake:",
      "line": 237,
      "preview": "- Cycle this TPN"
    },
    {
      "type": "text",
      "section": "Total Fluid Intake:",
      "line": 238,
      "preview": "- Infuse over: 24 hours"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "FAT EMULSION:",
      "line": 240
    },
    {
      "type": "text",
      "section": "FAT EMULSION:",
      "line": 241,
      "preview": "- Intralipid: 20% (gm/kg, to run over): 24 hours"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 243
    },
    {
      "type": "text",
      "section": "IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 244,
      "preview": "- Additive"
    },
    {
      "type": "text",
      "section": "IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 245,
      "preview": "- Additive"
    },
    {
      "type": "text",
      "section": "IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 246,
      "preview": "- Additive"
    },
    {
      "type": "text",
      "section": "IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 247,
      "preview": "- Additive"
    },
    {
      "type": "text",
      "section": "IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 248,
      "preview": "- Additive"
    },
    {
      "type": "text",
      "section": "IF fluid volumes from NON-NUTRITIONAL LINES are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 249,
      "preview": "- Additive"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 251
    },
    {
      "type": "text",
      "section": "IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 252,
      "preview": "- Enteral Feeding"
    },
    {
      "type": "text",
      "section": "IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 253,
      "preview": "- Feeding volume of: mls every: hours of: 1500"
    },
    {
      "type": "text",
      "section": "IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE, complete the following:",
      "line": 254,
      "preview": "- Strength: Breast Milk/MBM: 150"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Amino Acids",
      "line": 256
    },
    {
      "type": "text",
      "section": "Amino Acids",
      "line": 258,
      "preview": "- **Trophamine:** For patients \u22646 months, long-term PN patients, pre-liver transplant"
    },
    {
      "type": "text",
      "section": "Amino Acids",
      "line": 259,
      "preview": "- **Travasol:** All other patients"
    },
    {
      "type": "image",
      "section": "Amino Acids",
      "line": 261,
      "content": "![img-5.jpeg](images/f32f4c27549af6ed.png)"
    },
    {
      "type": "image",
      "section": "Amino Acids",
      "line": 263,
      "content": "![img-6.jpeg](images/b47cebfa11ba4ff7.png)"
    },
    {
      "type": "text",
      "section": "Amino Acids",
      "line": 265,
      "preview": "--- page 9 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 2: Fluids & Macros",
      "line": 267
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 269,
      "preview": "|  Weight (kg) |  |  |  |  |  |  |  | Fill this Order |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 270,
      "preview": "| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 271,
      "preview": "|   |  |  |  |  |  |  |  |  | Yesterday's Order: 278697 |  |  |  |  | Based on Last Order: 278697  |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 272,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 273,
      "preview": "|  PN Access Method: |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 274,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 275,
      "preview": "|  Total Fluid Intake: |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 276,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 277,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 278,
      "preview": "|  FAT EMULSION: |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 279,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 280,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 281,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 282,
      "preview": "|  IF fluid |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 283,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 284,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 285,
      "preview": "|  Additive |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 286,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 287,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 288,
      "preview": "|  Additive |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 289,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 290,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 291,
      "preview": "|  Additive |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 292,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 293,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 294,
      "preview": "|  Additive |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 295,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 296,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 297,
      "preview": "|  IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE, complete the follow"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 298,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 299,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 300,
      "preview": "|  Additive |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 301,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 302,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 303,
      "preview": "|  Additive |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 304,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 305,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 306,
      "preview": "|  Additive |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 307,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 308,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 309,
      "preview": "|  IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE |  |  |  |  |  |  | "
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 310,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 311,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 312,
      "preview": "|  IF fluid volumes from ENTERAL FEEDS are to be INCLUDED in TOTAL FLUID INTAKE |  |  |  |  |  |  | "
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 313,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 314,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 315,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 316,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 317,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 318,
      "preview": "|  AMINO ACIDS: |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 319,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 320,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 321,
      "preview": "|  DEXTROSE: |  |  |  |  |  |  |  |  |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 322,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 323,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 324,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 325,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 326,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 327,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 328,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 329,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 330,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 331,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 332,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 333,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 334,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 335,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 336,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 337,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 338,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 339,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 340,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 341,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 342,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 343,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 344,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 345,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 346,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 347,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 348,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 349,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 350,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 351,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Step 2: Fluids & Macros",
      "line": 352,
      "preview": "|  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |"
    },
    {
      "type": "text",
      "section": "Step 2: Fluids & Macros",
      "line": 355,
      "preview": "--- page 10 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 3: Micronutrients & Additives",
      "line": 357
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Step 3: Electrolytes / Vitamins / Other Additives",
      "line": 359
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 361
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 363,
      "preview": "- **Hover over \"Electrolyte Name\" and \"Electrolytes\" to see app:**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 364,
      "preview": "- **NICU**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 365,
      "preview": "- Peripheral: no heparin"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 366,
      "preview": "- Central: heparin 0.5 units/mL"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 367,
      "preview": "- **Nitrates and Minerals: Order per guidelines**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 368,
      "preview": "- **Adjusted D**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 369,
      "preview": "- **Heparin**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 370,
      "preview": "- **Vitamin K (additional)**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 371,
      "preview": "- **Potassium**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 372,
      "preview": "- **Vitamin K (additional)**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 373,
      "preview": "- **Nitrates (0-2 units/mL)**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 374,
      "preview": "- **ZINC (additional)**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 375,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 376,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 377,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 378,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 379,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 380,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 381,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 382,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 383,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 384,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 385,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 386,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 387,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 388,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 389,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 390,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 391,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 392,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 393,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 394,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 395,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 396,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 397,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 398,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 399,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 400,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 401,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 402,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 403,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 404,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 405,
      "preview": "- **PEDIATRIC M.V.I**"
    },
    {
      "type": "text",
      "section": "Hover over \"Additive Entry Box\" to see protocol guidelines",
      "line": 408,
      "preview": "--- page 11 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 3: Micronutrients & Additives",
      "line": 410
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Step 3: Electrolytes / Vitamins / Other Additives",
      "line": 412
    },
    {
      "type": "text",
      "section": "Step 3: Electrolytes / Vitamins / Other Additives",
      "line": 414,
      "preview": "**Hover over \"Additive Entry Box\" to see protocol guidelines**"
    },
    {
      "type": "text",
      "section": "Step 3: Electrolytes / Vitamins / Other Additives",
      "line": 416,
      "preview": "**Hover over \"Electrolyte Name\" and \"Electrolytes\" to see appropriate serum lab values if they are a"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Vitamins and Minerals: Order per guidelines",
      "line": 418
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals: Order per guidelines",
      "line": 420,
      "preview": "**Adjusted Dose Limits**"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals: Order per guidelines",
      "line": 422,
      "preview": "|  |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals: Order per guidelines",
      "line": 423,
      "preview": "| --- | --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals: Order per guidelines",
      "line": 424,
      "preview": "|  ZINC (additional) | 400 | mcg/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals: Order per guidelines",
      "line": 425,
      "preview": "|  PEDIATRIC M.V.I | 2 | ml/kg | 0 - 2 |  |   |"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Liver Function Tests",
      "line": 427
    },
    {
      "type": "text",
      "section": "Liver Function Tests",
      "line": 429,
      "preview": "**Hover over the \"Electrolyte Name\" to see recent serum lab value**"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 431,
      "preview": "|  |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 432,
      "preview": "| --- | --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 433,
      "preview": "|  SODIUM | 7 | mEq/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 434,
      "preview": "|  Na: 134 @ 06:07 AM | 4 | mEq/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 435,
      "preview": "|  CALCIUM GLUCONATE | 500 | mg/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 436,
      "preview": "|  PHOSPHATE | 2.2 | mM/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 437,
      "preview": "|  ACETATE | 4.1 | mEq/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Liver Function Tests",
      "line": 438,
      "preview": "|  MAGNESIUM | 0.7 | mEq/kg |  |  |   |"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 440
    },
    {
      "type": "text",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 442,
      "preview": "**Dose Limits**"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 444,
      "preview": "|  |   |   |   |   |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 445,
      "preview": "| --- | --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 446,
      "preview": "|  HEPARIN | 0.5 | units/ml |  |  |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 447,
      "preview": "|  Vitamin K (additional) | 0 | mg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 448,
      "preview": "|  COPPER | 20 | mcg/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 449,
      "preview": "|  SELENIUM | 0 | mcg/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 450,
      "preview": "|  CARNITINE | 5 | mg/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 451,
      "preview": "|  L-CYSTEINE | 0 | mg/gm AA |  |  |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 452,
      "preview": "|  FAMOTIDINE | 0 | mg/kg |  |  |   |"
    },
    {
      "type": "table",
      "section": "Supplementation Additives: Order only as needed unless default value present",
      "line": 453,
      "preview": "|  RANITIDINE | 0 | mg/kg |  |  |   |"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Epoetin",
      "line": 455
    },
    {
      "type": "text",
      "section": "Epoetin",
      "line": 457,
      "preview": "0 units/kg"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Other Additives",
      "line": 459
    },
    {
      "type": "table",
      "section": "Other Additives",
      "line": 461,
      "preview": "|  Dose |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | "
    },
    {
      "type": "text",
      "section": "Other Additives",
      "line": 463,
      "preview": "--- page 12 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Adjusting Electrolytes",
      "line": 465
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 467,
      "preview": "|   | Preterm Neonates | Infants/Children | Adolescents \\& Children Greater than 50 kg  |"
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 468,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 469,
      "preview": "|  Sodium | $2-5 \\mathrm{mEq} / \\mathrm{kg}$ | $2-5 \\mathrm{mEq} / \\mathrm{kg}$ | $1-2 \\mathrm{mEq} "
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 470,
      "preview": "|  Potassium | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $1-2 \\mathrm{mE"
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 471,
      "preview": "|  Calcium | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $0.5-4 \\mathrm{mEq} / \\mathrm{kg}$ | $10-20 \\mathrm{"
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 472,
      "preview": "|  Phosphorus | $1-2 \\mathrm{mmol} / \\mathrm{kg}$ | $0.5-2 \\mathrm{mmol} / \\mathrm{kg}$ | $10-40 \\ma"
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 473,
      "preview": "|  Magnesium | $0.3-0.5 \\mathrm{mEq} / \\mathrm{kg}$ | $0.3-0.5 \\mathrm{mEq} / \\mathrm{kg}$ | $10-30 "
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 474,
      "preview": "|  Acetate | As needed to maintain acid base-balance |  |   |"
    },
    {
      "type": "table",
      "section": "Adjusting Electrolytes",
      "line": 475,
      "preview": "|  Chloride | As needed to maintain acid base-balance |  |   |"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Considerations",
      "line": 477
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 479,
      "preview": "- Patient's weight (> 50 kg )"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 480,
      "preview": "- Renal function (renally-cleared lytes $=\\mathrm{K}, \\mathrm{Mg}$, Phos)"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 481,
      "preview": "- Labs and fluid status"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 482,
      "preview": "- Medications that may affect electrolytes (i.e., diuretics, supplements, dialysate)"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 483,
      "preview": "- Electrolyte repletions received outside of TPN (IV and enteral)"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 484,
      "preview": "- Potassium repletion $=0.3$ to $0.5 \\mathrm{mEq} / \\mathrm{kg} /$ dose (max $30 \\mathrm{mEq} /$ dos"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 485,
      "preview": "- Magnesium repletion $=0.2$ to $0.4 \\mathrm{mEq} / \\mathrm{kg}$ dose (max $16 \\mathrm{mEq} /$ dose)"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 486,
      "preview": "- Phosphate repletion $=0.16$ to $0.32 \\mathrm{mMol} / \\mathrm{kg} /$ dose (max $15 \\mathrm{mMol} /$"
    },
    {
      "type": "text",
      "section": "Considerations",
      "line": 488,
      "preview": "--- page 13 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 4: Submit... but Wait!",
      "line": 490
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 492,
      "preview": "|  TPN Order for Test, Patient (Ped) [MRN: 00000040] |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 493,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 494,
      "preview": "|  Step 4: Formulation Results | Close  |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 495,
      "preview": "|  Part 1: Verify Order |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 496,
      "preview": "|  Check Ca-PO4 PPT Curves |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 497,
      "preview": "|  Enter Number of Days of Compounding: 1 |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 498,
      "preview": "|  Preview Labels |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 499,
      "preview": "|  View Fat Emulsion Label | View Content Label  |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 500,
      "preview": "|  View Mixing Instructions | View Summary Label  |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 501,
      "preview": "|  Redo Current Order | Cancel Current Order  |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 502,
      "preview": "|  Part 2: Submit Order |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 503,
      "preview": "|  Submit for Pharmacy Review |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 504,
      "preview": "|  Part 3: Enter New Order |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 505,
      "preview": "|  Enter Next Order |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 507,
      "preview": "|  Mixing Instructions |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 508,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 509,
      "preview": "|  Lucile Salter Packard Childrens Hospital |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 510,
      "preview": "|  PN MIXING INSTRUCTIONS |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 511,
      "preview": "|  Order: |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 512,
      "preview": "|  (PENDING) for Bag 1 Due: 05-Jul-2022 @ 19:00 hrs |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 513,
      "preview": "|  Test. Patient (Ped) Unit: 2N |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 514,
      "preview": "|  Med Rec #: 00000040 |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 515,
      "preview": "|  CSN #: 000000040 |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 516,
      "preview": "|  PLACE THE FOLLOWING IN THE CONTAINER |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 517,
      "preview": "|  Travasol 10% | 885.7 ml  |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 518,
      "preview": "|  D70 | 221.4 ml Zinc [1000 mcg/ml] 5.54 ml  |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 519,
      "preview": "|  NaCl [4 mEq/ml] 40.56 ml |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 520,
      "preview": "|  NaPO4 [4 mEqNa/3 mMPO4] 2.95 ml Pedi MVI | 5.54 ml  |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 521,
      "preview": "|  NaAct [2 mEq/ml] 0.89 ml |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 522,
      "preview": "|  KCl [2 mEq/ml] 22.14 ml Magnesium [4 mEq/ml] 2.21 ml |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 523,
      "preview": "|  Calcium Gluc[100 mg/ml] 22.14 ml |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 524,
      "preview": "|  Copper [0.4 mg/ml] 1.38 ml |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 525,
      "preview": "|  Q.S. with 340 mls sterile H2O to total volume of 1550 mls. |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 526,
      "preview": "|  RI = 620.7 with a 10.0% range between 558.7 and 682.8 |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 527,
      "preview": "|  PPT Data: Amino Acid 5.71% Ca Gluc 1.4 gm/L PO4 5.7 mM/l |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 528,
      "preview": "|  Mg 5.7 mEq/L |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 529,
      "preview": "|  Final concentrations for K:29 mEq/L Na:114 mEq/L |   |"
    },
    {
      "type": "table",
      "section": "Step 4: Submit... but Wait!",
      "line": 530,
      "preview": "|  Dextrose Concentration 10%, PN Osmolarity 1373 mOsm/Liter |   |"
    },
    {
      "type": "image",
      "section": "Step 4: Submit... but Wait!",
      "line": 532,
      "content": "![img-7.jpeg](images/5bb8c7bf2a4716a5.png)"
    },
    {
      "type": "text",
      "section": "Step 4: Submit... but Wait!",
      "line": 534,
      "preview": "--- page 14 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 4: Submit... but Wait!",
      "line": 536
    },
    {
      "type": "image",
      "section": "Step 4: Submit... but Wait!",
      "line": 538,
      "content": "![img-8.jpeg](images/bfb11d5ff61d0284.png)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Step 4: Formulation Results",
      "line": 540
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 542,
      "preview": "- **Part 1: Verify Order**"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 543,
      "preview": "- Check Ca - PO4 PPT Curves"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 544,
      "preview": "- Enter Number of Days of Compounding: 1"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 545,
      "preview": "- Preview Labels"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 546,
      "preview": "- View Fat Emulsion Label"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 547,
      "preview": "- View Content Label"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 548,
      "preview": "- View Mixing Instructions"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 549,
      "preview": "- View Summary Label"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 550,
      "preview": "- Redo Current Order"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 551,
      "preview": "- Cancel Current Order"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 553,
      "preview": "- **Part 2: Submit Order**"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 554,
      "preview": "- Submit for Pharmacy Review"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 556,
      "preview": "- **Part 3: Enter New Order**"
    },
    {
      "type": "text",
      "section": "Step 4: Formulation Results",
      "line": 557,
      "preview": "- Enter Next Order"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Step 5: Proceed to the following steps:",
      "line": 559
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 561,
      "preview": "1. **TrophAmine 3.0% D20**"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 562,
      "preview": "- This PN contains TrophAmine at a final concentration of 3.5% and 10% Dextrose. Magnesium concentra"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 563,
      "preview": "- This PN's plotted point represents:"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 564,
      "preview": "- Phosphate concentration of 5.9 (mMol/L)"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 565,
      "preview": "- Calcium Gluconate concentration of 4.7 (gm/L)"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 566,
      "preview": "- **TrophAmine 3% Dextrose 20%**"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 568,
      "preview": "2. **Calcium Phosphate Solubility**"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 569,
      "preview": "- Calcium-phosphate solubility curves for parenteral nutrient solutions containing amino acids 3% an"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 570,
      "preview": "- **Phosphate (mMol/L)**"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 571,
      "preview": "- Calcium-phosphate solubility curves for pre- and post-detoxication solutions containing amino acid"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 573,
      "preview": "3. **Check Calcium-Phos curve for precipitation**"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 574,
      "preview": "- (Find curve closest to your final AA concentration and % dextrose)"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 576,
      "preview": "4. **Stanford Medicine**"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 577,
      "preview": "- **Stanford**"
    },
    {
      "type": "text",
      "section": "Step 5: Proceed to the following steps:",
      "line": 579,
      "preview": "--- page 15 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "**Manual of Pediatric Parenteral Nutrition**",
      "line": 581
    },
    {
      "type": "text",
      "section": "**Manual of Pediatric Parenteral Nutrition**",
      "line": 583,
      "preview": "**JOHN A. KERNER, JR., EDITOR**"
    },
    {
      "type": "image",
      "section": "**Manual of Pediatric Parenteral Nutrition**",
      "line": 585,
      "content": "![img-9.jpeg](images/909e5c78415a1be7.png)"
    },
    {
      "type": "image",
      "section": "**Manual of Pediatric Parenteral Nutrition**",
      "line": 587,
      "content": "![img-10.jpeg](images/be2e4b6763e9f1b1.png)"
    },
    {
      "type": "image",
      "section": "**Manual of Pediatric Parenteral Nutrition**",
      "line": 589,
      "content": "![img-11.jpeg](images/1bc8d0dfa80f3cfa.png)"
    },
    {
      "type": "text",
      "section": "**Manual of Pediatric Parenteral Nutrition**",
      "line": 591,
      "preview": "--- page 16 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Educational Tools",
      "line": 593
    },
    {
      "type": "text",
      "section": "Educational Tools",
      "line": 595,
      "preview": "http://med.stanford.edu/peds/rotations/core/green-team-educational-tools.html"
    },
    {
      "type": "image",
      "section": "Educational Tools",
      "line": 597,
      "content": "![img-12.jpeg](images/9e65f41df1627a7f.png)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SPECIALIZED NUTRITION SUPPORT TUTORIAL",
      "line": 599
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Writing Parenteral Nutrition Orders",
      "line": 600
    },
    {
      "type": "heading",
      "level": 2,
      "section": "OVERVIEW",
      "line": 602
    },
    {
      "type": "heading",
      "level": 2,
      "section": "NUTRITION IN PEDIATRICS",
      "line": 604
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Basic Science \u2022 Clinical Applications",
      "line": 605
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Parenteral Nutrition",
      "line": 607
    },
    {
      "type": "heading",
      "level": 3,
      "section": "John A. Kerner Jr., MD",
      "line": 608
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Melissa Hurwitz, MD",
      "line": 609
    },
    {
      "type": "text",
      "section": "Melissa Hurwitz, MD",
      "line": 611,
      "preview": "--- page 17 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Resources",
      "line": 613
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 615,
      "preview": "- LPCH Home Pharmacy"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 616,
      "preview": "- Call page operator - On call 24/ 7!"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 617,
      "preview": "- Recipes can be faxed"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 618,
      "preview": "- Business hours: 650-497-8316"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 619,
      "preview": "- LPCH Inpatient TPN Pharmacy"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 620,
      "preview": "- 650-497-8779"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 621,
      "preview": "- TPN RN Specialists"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 622,
      "preview": "- Margret (Allyn) Tabunda, BSN, RN, CFN"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 623,
      "preview": "- AlTabunda@stanfordchildrens.org"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 624,
      "preview": "- LPCH RD's (members of Nutrition Support Team)"
    },
    {
      "type": "text",
      "section": "Resources",
      "line": 626,
      "preview": "--- page 18 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 628
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 630,
      "preview": "Indications for PN use in children include:"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 632,
      "preview": "- Any child who cannot meet their nutritional requirements via oral or enteral route within 5-7 days"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 633,
      "preview": "- Clear liquid diet or poor intake $>5-7$ days"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 634,
      "preview": "- Non-functional GI tract for $>5-7$ days"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 635,
      "preview": "- Serious injury or illness preventing adequate enteral intake $>5$ days"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 636,
      "preview": "- Intolerance of enteral feeding"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 637,
      "preview": "- Malnourished child with poor intake or enteral intolerance"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 639,
      "preview": "--- page 19 ---"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 641,
      "preview": "Table I: Digestive indications for parenteral nutrition."
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 643,
      "preview": "Malabsorption medical and/or surgical"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 644,
      "preview": "Protracted and intractable diarrhoea"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 645,
      "preview": "Short bowel syndrome"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 646,
      "preview": "Enterocutaneous fistula"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 647,
      "preview": "Proximal enterostomy"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 648,
      "preview": "Intestinal bacterial overgrowth"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 649,
      "preview": "Immune deficiency"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 651,
      "preview": "Indication of bowel rest"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 652,
      "preview": "Inflammatory bowel disease (Crohn's disease, ulcerative colitis, unidentified colitis)"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 653,
      "preview": "Necrotizing enterocolitis"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 654,
      "preview": "Intestinal lymphangiectasy"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 655,
      "preview": "Acute pancreatitis"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 656,
      "preview": "Gastric hypersecretion"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 657,
      "preview": "Systemic disease: Shonlein-Hennoch, periarteritis"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 658,
      "preview": "Radiation enteritis"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 660,
      "preview": "Congenital or acquired neonatal pathology of the GI tract"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 661,
      "preview": "Gastroschisis"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 662,
      "preview": "Omphalocele"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 663,
      "preview": "Meconial ileus"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 664,
      "preview": "Extensive small bowel resection"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 665,
      "preview": "Necrotizing enterocolitis"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 666,
      "preview": "Complicated Hirschsprung disease"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 667,
      "preview": "Chronic intestinal pseudo-obstruction syndrome"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 669,
      "preview": "--- page 20 ---"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 671,
      "preview": "Table II: Extra-digestive indications for parenteral nutrition."
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 673,
      "preview": "|  Neonatology | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 674,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 675,
      "preview": "|  Low-birth-weight infants (<1500 g) | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 676,
      "preview": "|  Intestinal failure | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 677,
      "preview": "|  Necrotizing enterocolitis | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 678,
      "preview": "|  Metabolic disease | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 679,
      "preview": "|  End-stage liver disease | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 680,
      "preview": "|  Inborn errors of metabolism | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 681,
      "preview": "|  Cystic fibrosis | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 682,
      "preview": "|  Haematology and oncology | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 683,
      "preview": "|  Radiation/cytotoxic therapy: solid tumours, leukaemia | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 684,
      "preview": "|  Bone marrow transplantation | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 685,
      "preview": "|  Organ failure | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 686,
      "preview": "|  Acute liver failure | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 687,
      "preview": "|  Acute renal failure | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 688,
      "preview": "|  Hypercatabolism | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 689,
      "preview": "|  Extensive burns | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 690,
      "preview": "|  Severe trauma | |"
    },
    {
      "type": "table",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 691,
      "preview": "|  Major surgery | |"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 693,
      "preview": "--- page 21 ---"
    },
    {
      "type": "image",
      "section": "Indications for Parenteral Nutrition Use in Pediatric Patients",
      "line": 695,
      "content": "![img-13.jpeg](images/5374321333940de5.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Use PN only when Needed",
      "line": 697
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 699
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 701,
      "preview": "|  Parenteral | Mechanical | Enteral  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 702,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 703,
      "preview": "|  Venous thrombosis |  | Tube Blockage  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 704,
      "preview": "|  Catheter displacement/blockage |  | Balloon/button  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 705,
      "preview": "|   |  | Dysfunction/displacement  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 706,
      "preview": "|  Site/tunnel infection | Microbial |   |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 707,
      "preview": "|  Sepsis |  | Feeding contamination/  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 708,
      "preview": "|   |  | diarrhea/(sepsis)  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 709,
      "preview": "|  Under/over feeding | Metabolic |   |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 710,
      "preview": "|  Electrolyte disorders |  | Under/overfeeding  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 711,
      "preview": "|  Hypoglycemia, hyperglycemia |  |   |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 712,
      "preview": "|  Hypertriglyceridemia |  |   |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 713,
      "preview": "|  Glycosuria/dehydration |  |   |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 714,
      "preview": "|  Cholestatic liver disease | Organ specific |   |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 715,
      "preview": "|  Nephrocalcinosis |  | Diarrhea (drugs/antibiotics)  |"
    },
    {
      "type": "table",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 716,
      "preview": "|  Osteopenia |  |   |"
    },
    {
      "type": "text",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 718,
      "preview": "*From Merrit RJ and Abel A. \"The Safe and Appropriate Use of Parenteral Nutrition in Children.\" NASP"
    },
    {
      "type": "text",
      "section": "Potential Complications: Enteral vs. Parenteral Nutrition",
      "line": 720,
      "preview": "--- page 22 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Routes for IV Nutritional Support",
      "line": 722
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 724,
      "preview": "- Peripheral IV - generally short term, limited calories"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 725,
      "preview": "- Solution osmolality $>600-1000 \\mathrm{mOsm}$ leads to vein damage or occlusion (i.e., no more tha"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 726,
      "preview": "- Risk of severe local tissue damage with PN extravasation"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 727,
      "preview": "- Rarely indicated if PICC readily available"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 729,
      "preview": "--- page 23 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Routes for IV Nutritional Support",
      "line": 731
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 733,
      "preview": "- **Central venous catheter**\u2014useful for weeks or longer & allows full nutrition:"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 734,
      "preview": "- PICC suitable for many applications"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 735,
      "preview": "- Tunneled and/or cuffed catheters may be better in younger patients or for more extended use and wi"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 736,
      "preview": "- Double lumen only if need for frequent medications, fluids, blood (increased infection risk)"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 737,
      "preview": "- Ports\u2014Suitable when access need is intermittent"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 738,
      "preview": "- Larger lines may increase risk of DVT"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 739,
      "preview": "- Confirm central position with X-ray"
    },
    {
      "type": "image",
      "section": "Routes for IV Nutritional Support",
      "line": 741,
      "content": "![img-14.jpeg](images/7e90b0cb7e029650.png)"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 743,
      "preview": "*From* Merrit RJ and Abel A. \"The Safe and Appropriate Use of Parenteral Nutrition in Children.\" NAS"
    },
    {
      "type": "text",
      "section": "Routes for IV Nutritional Support",
      "line": 745,
      "preview": "--- page 24 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Fluid Needs for TPN",
      "line": 747
    },
    {
      "type": "text",
      "section": "Fluid Needs for TPN",
      "line": 749,
      "preview": "- Maintenance fluids may not mean maintenance calories."
    },
    {
      "type": "text",
      "section": "Fluid Needs for TPN",
      "line": 750,
      "preview": "- Monitor patient for excessive fluid retention (ie. excessive weight gain, edema, tachycardia, incr"
    },
    {
      "type": "text",
      "section": "Fluid Needs for TPN",
      "line": 751,
      "preview": "- Do not use TPN fluid as replacement fluid or resuscitation fluid. Can \"Y\" in replacement fluids du"
    },
    {
      "type": "text",
      "section": "Fluid Needs for TPN",
      "line": 752,
      "preview": "- Give special consideration to children with cardiovascular or renal disease."
    },
    {
      "type": "table",
      "section": "Fluid Needs for TPN",
      "line": 754,
      "preview": "|  Weight | Fluid Recommendations  |"
    },
    {
      "type": "table",
      "section": "Fluid Needs for TPN",
      "line": 755,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Fluid Needs for TPN",
      "line": 756,
      "preview": "|  $<10 \\mathrm{~kg}$ | $100-150 \\mathrm{ml} / \\mathrm{kg} /$ day  |"
    },
    {
      "type": "table",
      "section": "Fluid Needs for TPN",
      "line": 757,
      "preview": "|  $11-20 \\mathrm{~kg}$ | $1000 \\mathrm{ml}+50 \\mathrm{ml} / \\mathrm{kg}$ for each $\\mathrm{kg}>10 \\"
    },
    {
      "type": "table",
      "section": "Fluid Needs for TPN",
      "line": 758,
      "preview": "|  $>20 \\mathrm{~kg}$ | $1500 \\mathrm{ml}+20 \\mathrm{ml} / \\mathrm{kg}$ for each $\\mathrm{kg}>20 \\ma"
    },
    {
      "type": "table",
      "section": "Fluid Needs for TPN",
      "line": 759,
      "preview": "|  Any weight | 1500 to $1700 \\mathrm{ml} / \\mathrm{m}^{2} /$ day  |"
    },
    {
      "type": "text",
      "section": "Fluid Needs for TPN",
      "line": 761,
      "preview": "Merrit, R (ed). (2005) The A.S.P.E.N. Nutrition Support Practice Manual $2^{\\text {nd }}$ Edition. S"
    },
    {
      "type": "text",
      "section": "Fluid Needs for TPN",
      "line": 763,
      "preview": "--- page 25 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN Water and Electrolytes",
      "line": 765
    },
    {
      "type": "text",
      "section": "PN Water and Electrolytes",
      "line": 767,
      "preview": "- In most situations, start PN as 24 h infusion"
    },
    {
      "type": "text",
      "section": "PN Water and Electrolytes",
      "line": 768,
      "preview": "- Order fluid to meet patient needs according to age and weight requirements and consider any entera"
    },
    {
      "type": "text",
      "section": "PN Water and Electrolytes",
      "line": 769,
      "preview": "- Do not use PN for fluid replacement"
    },
    {
      "type": "text",
      "section": "PN Water and Electrolytes",
      "line": 771,
      "preview": "TABLE 6. PN ELECTROLYTE AND MINERAL DAILY DOSING*"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 773,
      "preview": "|   | Preterm Neonates | Infants/Children | Adolescents \\& Children"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 774,
      "preview": "Greater than 50 kg  |"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 775,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 776,
      "preview": "|  Sodium | $2-5 \\mathrm{mEq} / \\mathrm{kg}$ | $2-5 \\mathrm{mEq} / \\mathrm{kg}$ | $1-2 \\mathrm{mEq} "
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 777,
      "preview": "|  Potassium | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $1-2 \\mathrm{mE"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 778,
      "preview": "|  Calcium | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $0.5-4 \\mathrm{mEq} / \\mathrm{kg}$ | $10-20 \\mathrm{"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 779,
      "preview": "|  Phosphorus | $1-2 \\mathrm{mmol} / \\mathrm{kg}$ | $0.5-2 \\mathrm{mmol} / \\mathrm{kg}$ | $10-40 \\ma"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 780,
      "preview": "|  Magnesium | $0.3-0.5 \\mathrm{mEq} / \\mathrm{kg}$ | $0.3-0.5 \\mathrm{mEq} / \\mathrm{kg}$ | $10-30 "
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 781,
      "preview": "|  Acetate | As needed to maintain acid base-balance |  |   |"
    },
    {
      "type": "table",
      "section": "PN Water and Electrolytes",
      "line": 782,
      "preview": "|  Chloride | As needed to maintain acid base-balance |  |   |"
    },
    {
      "type": "text",
      "section": "PN Water and Electrolytes",
      "line": 784,
      "preview": "*Use caution in prescribing calcium and phosphorus related to compatibility."
    },
    {
      "type": "text",
      "section": "PN Water and Electrolytes",
      "line": 786,
      "preview": "From Merrit RJ and Abel A. \"The Safe and Appropriate Use of Parenteral Nutrition in Children.\" NASPG"
    },
    {
      "type": "text",
      "section": "PN Water and Electrolytes",
      "line": 788,
      "preview": "--- page 26 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Water and Electrolytes Special situations",
      "line": 790
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 792,
      "preview": "- Don't start PN with dehydration/electrolyte disorders"
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 793,
      "preview": "- Less sodium if edema or ascites"
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 794,
      "preview": "- Potassium and phosphorus levels may rise with even mild renal failure"
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 795,
      "preview": "- Malnutrition increases initial need for K, P, Mg (refeeding syndrome)"
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 796,
      "preview": "- Chemotherapy can increase Mg need"
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 797,
      "preview": "- Antifungal therapy may increase K, Ca \\& Mg need."
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 798,
      "preview": "- Acidosis may reflect diarrhea, dehydration, d-lactic acidosis or thiamin deficiency"
    },
    {
      "type": "text",
      "section": "Water and Electrolytes Special situations",
      "line": 800,
      "preview": "--- page 27 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "LPCH Non-NICU TPN Guide",
      "line": 802
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 804,
      "preview": "|  Age | Goal Weight Gain | Energy Need  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 805,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 806,
      "preview": "|  0-3 mo | $30 \\mathrm{~g} /$ day | $90-110 \\mathrm{kcal} / \\mathrm{kg} /$ day  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 807,
      "preview": "|  3-6 mo | $20 \\mathrm{~g} /$ day | $90-110 \\mathrm{kcal} / \\mathrm{kg} /$ day  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 808,
      "preview": "|  6-12 mo | $12 \\mathrm{~g} /$ day | $80-100 \\mathrm{kcal} / \\mathrm{kg} /$ day  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 809,
      "preview": "|  1-6 yr | $8 \\mathrm{~g} /$ day | $60-90 \\mathrm{kcal} / \\mathrm{kg} /$ day  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 810,
      "preview": "|  7-10 yr | $5-12 \\mathrm{~g} /$ day | $45-70 \\mathrm{kcal} / \\mathrm{kg} /$ day  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 811,
      "preview": "|  11-18 yr | $5-12 \\mathrm{~g} /$ day | $30-55 \\mathrm{kcal} / \\mathrm{kg} /$ day  |"
    },
    {
      "type": "text",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 813,
      "preview": "RDs may use sedentary Dietary Reference Index (DRI) for critically ill patients = lower range for kc"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 815,
      "preview": "|  Daily Carbohydrate Requirement |  |  |   |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 816,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 817,
      "preview": "|  Age | Initial | Advance | Goal (GIR)  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 818,
      "preview": "|  Infants (<1 yr) | D10 (6-9 mg/kg/min) | D 2.5 | $12 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 819,
      "preview": "(max 14-18)  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 820,
      "preview": "|  Children (1-10 yrs) | D10 | D 2.5-5 | $8-10 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 821,
      "preview": "|  Adolescent (11-18 yrs) | D10 | D 2.5-5 | $5-6 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$  |"
    },
    {
      "type": "text",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 823,
      "preview": "--- page 28 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "LPCH Non-NICU TPN Guide",
      "line": 825
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 827,
      "preview": "|  Daily Protein Requirement |  |  |   |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 828,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 829,
      "preview": "|  Age | Initial | Advance | Goal  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 830,
      "preview": "|  $<1$ yr | $1.5 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 831,
      "preview": "|  1-10 yrs | $1.2 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 832,
      "preview": "|  11-18 yrs | $1-1.5 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1 \\mathrm{~g} / \\mathrm{kg} / \\math"
    },
    {
      "type": "text",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 834,
      "preview": "*Trophamine for patients $<6 \\mathrm{mo}$ or on long term TPN* Travasol for patients $>6 \\mathrm{mo}"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 836,
      "preview": "|  Daily Lipid Requirement |  |  |   |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 837,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 838,
      "preview": "|  Age | Initial | Advance | Goal  |"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 839,
      "preview": "|  $<1$ yr | $1-2 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $0.5-1 \\mathrm{~g} / \\mathrm{kg} / \\math"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 840,
      "preview": "|  1-10 yrs | $1-2 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $0.5-1 \\mathrm{~g} / \\mathrm{kg} / \\mat"
    },
    {
      "type": "table",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 841,
      "preview": "|  11-18 yrs | $1 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d"
    },
    {
      "type": "text",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 843,
      "preview": "*If Dbili elevated $>2 \\mathrm{mg} / \\mathrm{dL}$, decrease IL to $1 \\mathrm{gm} / \\mathrm{kg} /$ da"
    },
    {
      "type": "text",
      "section": "LPCH Non-NICU TPN Guide",
      "line": 845,
      "preview": "--- page 29 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 847
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 849,
      "preview": "- Use to prevent EFAD and normalize distribution of calories (so not all from protein and sugar)"
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 850,
      "preview": "- Commonly given via separate pump in infants/young children rather than 3 in 1 solution due to de-s"
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 851,
      "preview": "- Usual doses given over 12-24 hrs/d"
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 852,
      "preview": "- North American default choice has been 20\\% soybean ILE given at target of $2-3 \\mathrm{~g} / \\mat"
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 853,
      "preview": "- Monitor serum TG or other marker of lipid concentration"
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 854,
      "preview": "- TG target $<150-250 \\mathrm{mg} / \\mathrm{dL}$ in infants; $<250-400 \\mathrm{mg} / \\mathrm{dL}$ in"
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 855,
      "preview": "- Risk of pancreatitis (if TG>400 mg/dL) and kernicterus in infants with hypertriglyceridemia and in"
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 856,
      "preview": "- Some patients may benefit from a balanced ILE (e.g., Smoflipid ${ }^{\\circledR}$ ) or IV fish oil "
    },
    {
      "type": "text",
      "section": "Intravenous Lipid Emulsions (ILE)",
      "line": 858,
      "preview": "--- page 30 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TrophAmine\u00ae",
      "line": 860
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae",
      "line": 862,
      "preview": "\"TrophAmine\u00ae is an amino acid solution originally developed to simulate the plasma amino acid profil"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae",
      "line": 864,
      "preview": "* Kaufman S: Pediatric Transplantation 6:37, 2002."
    },
    {
      "type": "image",
      "section": "TrophAmine\u00ae",
      "line": 866,
      "content": "![img-15.jpeg](images/7a16165fdfa9d2c2.png)"
    },
    {
      "type": "image",
      "section": "TrophAmine\u00ae",
      "line": 868,
      "content": "![img-16.jpeg](images/1fb22f9f3cee5614.png)"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae",
      "line": 870,
      "preview": "--- page 31 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 872
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 874,
      "preview": "|   |  | TrophAmine\u00ae"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 875,
      "preview": "(6% and 10%"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 876,
      "preview": "Amino Acid Injections) | Standard Adult"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 877,
      "preview": "Amino Acid Solutions  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 878,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 879,
      "preview": "|  Additional Essential Amino Acids"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 880,
      "preview": "in Children | Cysteine | \u2611 |   |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 881,
      "preview": "|   | Histidine | \u2611 |   |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 882,
      "preview": "|   | Tyrosine | \u2611 |   |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 883,
      "preview": "|  Conditionally Essential Amino Acid | Taurine | \u2611 |   |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 884,
      "preview": "|  Essential Amino Acids | Isoleucine | \u2611 | \u2611  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 885,
      "preview": "|   | Leucine | \u2611 | \u2611  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 886,
      "preview": "|   | Lysine | \u2611 | \u2611  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 887,
      "preview": "|   | Methionine | \u2611 | \u2611  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 888,
      "preview": "|   | Phenylalanine | \u2611 | \u2611  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 889,
      "preview": "|   | Threonine | \u2611 | \u2611  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 890,
      "preview": "|   | Tryptophan | \u2611 | \u2611  |"
    },
    {
      "type": "table",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 891,
      "preview": "|   | Valine | \u2611 | \u2611  |"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 893,
      "preview": "T-19"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 895,
      "preview": "Transthema crassum L. (Trophamine\u00ae) 100% and 100% Amino Acid Injections"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 897,
      "preview": "Trophamine\u00ae (6% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 899,
      "preview": "Trophamine\u00ae (6% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 901,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 903,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 905,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 907,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 909,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 911,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 913,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 915,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 917,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 919,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 921,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 923,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 925,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 927,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 929,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 931,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 933,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 935,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 937,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 939,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 941,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 943,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 945,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 947,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 949,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 951,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 953,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 955,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 957,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 959,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 961,
      "preview": "Trophamine\u00ae (10% and 10% Amino Acid Injections) Standard Adult Amino Acid Solutions"
    },
    {
      "type": "text",
      "section": "TrophAmine\u00ae versus Standard Amino Acids",
      "line": 965,
      "preview": "--- page 32 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Trophamine vs. Travasol",
      "line": 967
    },
    {
      "type": "text",
      "section": "Trophamine vs. Travasol",
      "line": 969,
      "preview": "- Trophamine - more protective against TPN cholestasis"
    },
    {
      "type": "text",
      "section": "Trophamine vs. Travasol",
      "line": 970,
      "preview": "- Patients on long term PN"
    },
    {
      "type": "text",
      "section": "Trophamine vs. Travasol",
      "line": 971,
      "preview": "- Preemies and infants at least to 6 months"
    },
    {
      "type": "text",
      "section": "Trophamine vs. Travasol",
      "line": 972,
      "preview": "- Travasol for everyone else"
    },
    {
      "type": "text",
      "section": "Trophamine vs. Travasol",
      "line": 973,
      "preview": "- Short term TPN"
    },
    {
      "type": "text",
      "section": "Trophamine vs. Travasol",
      "line": 974,
      "preview": "- Cheaper!"
    },
    {
      "type": "text",
      "section": "Trophamine vs. Travasol",
      "line": 976,
      "preview": "--- page 33 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "**ROPHAMINE**",
      "line": 978
    },
    {
      "type": "image",
      "section": "**ROPHAMINE**",
      "line": 980,
      "content": "![img-17.jpeg](images/fd260a4c9c44dfa6.png)"
    },
    {
      "type": "image",
      "section": "**ROPHAMINE**",
      "line": 982,
      "content": "![img-18.jpeg](images/676752adf0e60850.png)"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 984,
      "preview": "--- page 34 ---"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 986,
      "preview": "Table. 4-24. Recommendations for Initiation and Advancement of Macronutrients in Parenteral Nutritio"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 988,
      "preview": "|   | INITIATION |  | ADVANCE BY |  | GOALS |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 989,
      "preview": "| --- | --- | --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 990,
      "preview": "|  INFANTS ( $<1 \\mathrm{y}$ ) | PRETERM | TERM | PRETERM | TERM | PRETERM | TERM  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 991,
      "preview": "|  Protein ( $\\mathrm{g} / \\mathrm{kg} /$ day $)^{\\mathrm{a}}$ | $3-4$ | $2.5-3$ | -- | -- | $3-4$ |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 992,
      "preview": "|  Dextrose ( $\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$ ) | $6-8$ | $6-8$ | $1.4-1.7$ | 3.5 | $10-1"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 993,
      "preview": "|  Fat ( $\\mathrm{g} / \\mathrm{kg} /$ day) | $0.5-1$ | $0.5-1$ | $0.5-1$ | $0.5-1$ | 3 (max $0.15 \\m"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 994,
      "preview": "|  CHILDREN (1-10 y) |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 995,
      "preview": "|  Protein ( $\\mathrm{g} / \\mathrm{kg} /$ day) | $1.5-2.5$ |  | -- |  | $1.5-2.5$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 996,
      "preview": "|  Dextrose ( $\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$ ) | $3-6$ |  | $2-3$ |  | $8-10$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 997,
      "preview": "|  Fat ( $\\mathrm{g} / \\mathrm{kg} /$ day) | $1-2$ |  | $0.5-1$ |  | $2-2.5$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 998,
      "preview": "|  ADOLESCENTS |  |  |  |  |  |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 999,
      "preview": "|  Protein ( $\\mathrm{g} / \\mathrm{kg} /$ day) | $0.8-2$ |  | -- |  | $0.8-2$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1000,
      "preview": "|  Dextrose ( $\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$ ) | $2.5-3$ |  | $1-2$ |  | $5-6$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1001,
      "preview": "|  Fat ( $\\mathrm{g} / \\mathrm{kg} /$ day) | 1 |  | 1 |  | $1-2$ |   |"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 1003,
      "preview": "Glucose infusion rate ( $\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$ ) $=[$ dextrose $(\\mathrm{g} /$ d"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 1005,
      "preview": "--- page 35 ---"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 1007,
      "preview": "Monitoring Recommendations for TPN"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1009,
      "preview": "|  Variable | Initial | Daily | Weekly  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1010,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1011,
      "preview": "|  Weight | $x$ | $x$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1012,
      "preview": "|  Length and head circumference | $x^{*}$ |  |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1013,
      "preview": "|  Physical exam | $x$ | $x$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1014,
      "preview": "|  Fluid balance | $x$ | $x$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1015,
      "preview": "|  $\\mathrm{Na}, \\mathrm{K}, \\mathrm{Cl}, \\mathrm{CO}_{2}$ | $x$ | $x$ | $x^{ }$  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1016,
      "preview": "|  Ca, Phos, Mg | $x$ | $x$ (while advancing) | $x$  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1017,
      "preview": "|  Glucose | $x$ | $x$ | $x^{ }$  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1018,
      "preview": "|  BUN/Cr | $x$ | $x$ (while advancing) | $x$  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1019,
      "preview": "|  Liver profile | $x$ |  | $x$  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1020,
      "preview": "|  Triglycerides | $x^{ *** }$ |  | $x$  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1021,
      "preview": "|  Urine glucose | $x$ | $x$ |   |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1022,
      "preview": "|  Complete blood count | $x$ |  | $x$  |"
    },
    {
      "type": "table",
      "section": "**ROPHAMINE**",
      "line": 1023,
      "preview": "|  Prealbumin | $x$ |  | $x$  |"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 1025,
      "preview": "*Initially, then monthly* *daily until stable, then once or twice weekly* **Initially and before eac"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 1027,
      "preview": "NOTE: The above represents minimum guidelines, and lab checks may need to be more frequent depending"
    },
    {
      "type": "text",
      "section": "**ROPHAMINE**",
      "line": 1029,
      "preview": "--- page 36 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring TPN",
      "line": 1031
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Monitoring",
      "line": 1033
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1035,
      "preview": "1. Initiate \"TPN Monitoring\" lab order set in Epic"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1037,
      "preview": "- Prior to ordering TPN = CBC, Chem23 (MetC, Mg, Phos, triglyceride, D-bili, GGT), Coags, UA"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1038,
      "preview": "- CXR to insure proper placement of central line"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1039,
      "preview": "- TPN days 1-4 = Daily renal function panel, Mg, triglyceride, and UA"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1040,
      "preview": "- Long Term inpatient monitoring"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1041,
      "preview": "- qMonday = CBC, Chem23 (MetC, Mg, PO4, D-bili, GGT, triglyceride)"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1042,
      "preview": "- qThursday = Renal function panel, magnesium, triglyceride"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 1044,
      "preview": "--- page 37 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring TPN",
      "line": 1046
    },
    {
      "type": "table",
      "section": "Monitoring TPN",
      "line": 1048,
      "preview": "|  Order and Order Set Search |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring TPN",
      "line": 1049,
      "preview": "| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --"
    },
    {
      "type": "table",
      "section": "Monitoring TPN",
      "line": 1050,
      "preview": "|  TPN |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  "
    },
    {
      "type": "table",
      "section": "Monitoring TPN",
      "line": 1051,
      "preview": "|  Order Sets & Panels |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | "
    },
    {
      "type": "table",
      "section": "Monitoring TPN",
      "line": 1052,
      "preview": "|  Name |  | User Version Name |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  "
    },
    {
      "type": "table",
      "section": "Monitoring TPN",
      "line": 1053,
      "preview": "|  TPN Monitoring (Established) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | "
    },
    {
      "type": "table",
      "section": "Monitoring TPN",
      "line": 1054,
      "preview": "|  TPN Monitoring (Initiation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  "
    },
    {
      "type": "image",
      "section": "Monitoring TPN",
      "line": 1056,
      "content": "![img-19.jpeg](images/204c10a5996f71b9.png)"
    },
    {
      "type": "text",
      "section": "Monitoring TPN",
      "line": 1058,
      "preview": "--- page 38 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrients",
      "line": 1060
    },
    {
      "type": "image",
      "section": "Micronutrients",
      "line": 1062,
      "content": "![img-20.jpeg](images/b825150b69b9f5df.png)"
    },
    {
      "type": "image",
      "section": "Micronutrients",
      "line": 1064,
      "content": "![img-21.jpeg](images/a531cd2affae2795.png)"
    },
    {
      "type": "image",
      "section": "Micronutrients",
      "line": 1066,
      "content": "![img-22.jpeg](images/a1b5eb3073496fb0.png)"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1068,
      "preview": "--- page 39 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Trace Elements",
      "line": 1070
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1072,
      "preview": "- Manganese*"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1073,
      "preview": "- Copper*"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1074,
      "preview": "(some elimination in urine)"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1075,
      "preview": "- Excreted in Bile"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1077,
      "preview": "*Have the dose decreased when obstructive jaundice is present"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1079,
      "preview": "- Selenium\u2020"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1080,
      "preview": "- Molybdenum \u2020"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1081,
      "preview": "- Chromium \u2020"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1082,
      "preview": "- Excreted in Urine"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1084,
      "preview": "\u2020Should not be given when significant renal dysfunction is present"
    },
    {
      "type": "image",
      "section": "Trace Elements",
      "line": 1086,
      "content": "![img-23.jpeg](images/521142ebbbd17f81.png)"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1088,
      "preview": "--- page 40 ---"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1090,
      "preview": "Table 34-7 Trace Element Requirements*"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1092,
      "preview": "|  TRACE ELEMENT | PRETERM"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1093,
      "preview": "NEONATES"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1094,
      "preview": "$<3 \\mathrm{~kg}(\\mathrm{mcg} / \\mathrm{kg} / \\mathrm{d})$ | TERM NEONATES 3-"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1095,
      "preview": "10 kg"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1096,
      "preview": "(mcg/kg/d) | CHILDREN 10-40 kg"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1097,
      "preview": "(mcg/kg/d) | ADOLESCENTS $>40$"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1098,
      "preview": "kg (PER DAY)  |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1099,
      "preview": "| --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1100,
      "preview": "|  Zinc | 400 | $50-250$ | $50-125$ | $2-5 \\mathrm{mg}$  |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1101,
      "preview": "|  Copper | 20 | 20 | $5.0-20$ | $200-500 \\mathrm{mg}$  |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1102,
      "preview": "|  Manganese | 1 | 1 | 1 | $40-100 \\mathrm{mcg}$  |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1103,
      "preview": "|  Chromium | $0.05-0.2$ | 0.2 | $0.14-0.2$ | $5-15 \\mathrm{mcg}$  |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 1104,
      "preview": "|  Selenium | $1.5-2$ | 2 | $1.0-2$ | $40-60 \\mathrm{mcg}$  |"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1106,
      "preview": "*assumes normal organ function and losses"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1108,
      "preview": "In order to meet these trace element needs, one would need to use individual trace element products."
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1110,
      "preview": "Reprinted with permission from Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 1112,
      "preview": "--- page 41 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN Micronutrients",
      "line": 1114
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1116,
      "preview": "- Vitamins"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1117,
      "preview": "- Dose pediatric multivitamin preparation by age or weight"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1118,
      "preview": "- Give adult multivitamin preparation to adolescents"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1119,
      "preview": "- Trace elements (Individual addition preferred)"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1120,
      "preview": "- Zinc, copper, selenium required,"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1121,
      "preview": "- Consider chromium in infants"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1122,
      "preview": "- Multi-trace preparations may provide excess manganese \\& chromium and are generally best avoided"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1123,
      "preview": "- No FDA-approved PN sources of iron or iodine"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1124,
      "preview": "- ASPEN website (nutritioncare.org) has up-to-date guidelines re: micronutrient (and other) recurrin"
    },
    {
      "type": "text",
      "section": "PN Micronutrients",
      "line": 1126,
      "preview": "--- page 42 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Copper Deficiency",
      "line": 1128
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Clinical Sx.",
      "line": 1130
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1132,
      "preview": "Anorexia"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1133,
      "preview": "Failure to grow"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1134,
      "preview": "Diarrhea"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1135,
      "preview": "Pallor"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1136,
      "preview": "Depigmentation of hair \\& skin"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1137,
      "preview": "Dilated superficial veins"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1138,
      "preview": "Defective elastic formation (aneurysm)"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1139,
      "preview": "Central nervous system abnormalities"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1140,
      "preview": "Hypothermia"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1141,
      "preview": "Hepatosplenomegaly"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1142,
      "preview": "Bone fractures"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1144,
      "preview": "Lab Tests"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1145,
      "preview": "mild, early findings:"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1146,
      "preview": "Anemia (hypochromic)"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1147,
      "preview": "Neutropenia"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1148,
      "preview": "Osteopenia/Osteoporosis"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1149,
      "preview": "Periosteal reactions*"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1150,
      "preview": "Cupping of long bones*"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1151,
      "preview": "Flaring of anterior ribs*"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1152,
      "preview": "Submetaphyseal fractures*"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1154,
      "preview": "*These findings often resemble those of scurvy"
    },
    {
      "type": "text",
      "section": "Clinical Sx.",
      "line": 1156,
      "preview": "--- page 43 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases*",
      "line": 1158
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases*",
      "line": 1160,
      "preview": "- Trace elements held in 4 patients for c bili. $>2$"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases*",
      "line": 1161,
      "preview": "- Copper levels in these 4: 5-20 mcg/dL at their nadir"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases*",
      "line": 1162,
      "preview": "- Sx: Asymptomatic with no abnormalities $\\rightarrow$ symptomatic with evidence of anemia, leukopen"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases*",
      "line": 1164,
      "preview": "[^0]"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases*",
      "line": 1165,
      "preview": "[^0]:    *Hurwitz M et al. NCP 18:185, April 2003"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases*",
      "line": 1167,
      "preview": "--- page 44 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases* (cont'd)",
      "line": 1169
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases* (cont'd)",
      "line": 1171,
      "preview": "- All of these symptoms and lab abnormalities normalized after receiving copper I.V. at the standard"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases* (cont'd)",
      "line": 1172,
      "preview": "- We then gave reduced doses of copper I.V. (10 $\\mathrm{mcg} / \\mathrm{kg} /$ day) to avoid deficie"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases* (cont'd)",
      "line": 1173,
      "preview": "*Hurwitz M et al. NCP 18:185, April 2003"
    },
    {
      "type": "text",
      "section": "Copper Deficiency During TPN: A Report of 4 Pediatric Cases* (cont'd)",
      "line": 1175,
      "preview": "--- page 45 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Components of PN - Zinc (Zn)",
      "line": 1177
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1179,
      "preview": "- Zn is an important trace element especially in growth and wound healing"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1180,
      "preview": "- Signs of Zn deficiency"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1181,
      "preview": "- Dermatitis, alopecia, diarrhea, immune deficiency"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1182,
      "preview": "- *Mimics acrodermatitis enteropathica*"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1183,
      "preview": "- Zn excreted mainly in feces"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1184,
      "preview": "- Increased needs in diarrhea, hypercatabolic states, ostomy losses, mucositis, and chest tube losse"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1185,
      "preview": "- Measure of Zn status"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1186,
      "preview": "- Serum Zn is a poor measure but is the only measure clinically available"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1187,
      "preview": "- A low alkaline phosphatase may suggest Zn deficiency but this is not diagnostic"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1188,
      "preview": "- Can increase intake in PN to 1.5 - 2 times usual dose in conditions associated with increased need"
    },
    {
      "type": "image",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1190,
      "content": "![img-24.jpeg](images/d8eec9f0d4b3058f.png)"
    },
    {
      "type": "image",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1192,
      "content": "![img-25.jpeg](images/63162ef28c4dc0a2.png)"
    },
    {
      "type": "image",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1194,
      "content": "![img-26.jpeg](images/a174052ef1efaed1.png)"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1196,
      "preview": "Acknowledgement to dermnetnz.org"
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1198,
      "preview": "Report of WHO/ UNICEF/ IAEA/ IZiNCG. *Food Nutr Bull.* 2007;28:S399-S400."
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1200,
      "preview": "Woolf et al. *Dig Dis Sci.* 1987;32(1):8-15."
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1202,
      "preview": "Prasad et al. *J Lab Clin Med.* 1963;61:537-49."
    },
    {
      "type": "text",
      "section": "Components of PN - Zinc (Zn)",
      "line": 1204,
      "preview": "--- page 46 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Components of PN - Selenium (Se)",
      "line": 1206
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1208,
      "preview": "- Se deficiency can develop within 6 weeks of Se-free PN"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1209,
      "preview": "- Can cause cardiomyopathy, growth retardation, pseudo-albinism, white fingernails, and skin disorde"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1210,
      "preview": "- Suggested that patients be supplemented if on exclusive PN for >4 weeks"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1212,
      "preview": "- Toxicity is rare"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1213,
      "preview": "- Can cause nausea, diarrhea, irritability, fatigue, peripheral neuropathy, hair loss, nail changes"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1215,
      "preview": "- Total plasma selenium"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1216,
      "preview": "- Most widely used test of Se status"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1217,
      "preview": "- Fairly accurate"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1218,
      "preview": "- In the presence of systemic inflammation, levels decrease"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1220,
      "preview": "- In patients with impaired renal function, remove Se from PN and monitor levels"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1222,
      "preview": "Pediatric Nutrition Support Core Curriculum. Editor: M. Corkins. ASPEN, 2010."
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1223,
      "preview": "Masumoto et al. *Nutrition* 2007;23:782-87."
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1224,
      "preview": "Kanekura et al. *Clin Exp Dermatol.* 2005;30:346-48."
    },
    {
      "type": "image",
      "section": "Components of PN - Selenium (Se)",
      "line": 1226,
      "content": "![img-27.jpeg](images/b906464e562995f2.png)"
    },
    {
      "type": "text",
      "section": "Components of PN - Selenium (Se)",
      "line": 1228,
      "preview": "--- page 47 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Components of PN - Manganese (Mn)",
      "line": 1230
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1232,
      "preview": "- Deficiency is virtually unknown in humans"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1233,
      "preview": "- Various PN components are contaminated with Mn"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1234,
      "preview": "- Biliary tract is the predominant route for Mn excretion"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1235,
      "preview": "- Patients with cholestasis have decreased Mn excretion and may develop Mn toxicity"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1236,
      "preview": "- Toxicity"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1237,
      "preview": "- Symptoms include insomnia, headache, increased forgetfulness, anxiety and a Parkinson's disease-li"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1238,
      "preview": "- Best assessed by an MRI scan of the brain (manganese accumulates in the basal ganglia)"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1239,
      "preview": "- Monitoring"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1240,
      "preview": "- Regular monitoring of patients receiving fixed doses of Mn over prolonged periods is recommended"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1241,
      "preview": "- Erythrocyte or whole-blood Mn concentrations"
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1243,
      "preview": "Hardy et al. Curr Opin Clin Nutr Metab Care. 2008;11:289-96."
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1244,
      "preview": "Koletzko et al. J Pediatr Gastroenterol Nutr. 2005;41:S1-S87."
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1245,
      "preview": "Fell et al. Lancet 1996;347:1218-21."
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1246,
      "preview": "Kafritsa et al. Arch Dis Child. 1998;79:263-65."
    },
    {
      "type": "text",
      "section": "Components of PN - Manganese (Mn)",
      "line": 1248,
      "preview": "--- page 48 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1250
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1252,
      "preview": "- Daily administration of PN over a period of time which is < 24 hrs e.g., 8 - 22 hrs cycle; average"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1253,
      "preview": "- Pre-requisite"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1254,
      "preview": "- stable regimen"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1255,
      "preview": "- ability to handle large volume of fluid and nutrients over a short amount of time"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1256,
      "preview": "- The smaller the infant the less tolerant they may be of the cycle"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1257,
      "preview": "- Putative benefits"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1258,
      "preview": "- decreased hepatic steatosis"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1259,
      "preview": "- allows for a more normal daytime routine"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1260,
      "preview": "- increases mobility of the patient"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1261,
      "preview": "- Wean PN rate for the last hour by decreasing the rate by $50 \\%$. Consider starting the PN solutio"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1262,
      "preview": "- Check serum glucose 30 - 45 minutes after stopping PN with every change in length of cycle. Monito"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition - Cycling PN",
      "line": 1264,
      "preview": "--- page 49 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrients",
      "line": 1266
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1268,
      "preview": "- **Calcium**"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1269,
      "preview": "- Start: 200-350 mg/kg/d"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1270,
      "preview": "- Goal:"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1271,
      "preview": "- Pre-term: 400-550 mg/kg/d"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1272,
      "preview": "- Term: 300-400 mg/kg/d"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1274,
      "preview": "- **Phosphorus**"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1275,
      "preview": "- Start: 0.5 mM/kg/d"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1276,
      "preview": "- Goal: 1 mM/kg/d"
    },
    {
      "type": "image",
      "section": "Micronutrients",
      "line": 1278,
      "content": "![img-28.jpeg](images/f15796e840952237.png)"
    },
    {
      "type": "image",
      "section": "Micronutrients",
      "line": 1280,
      "content": "![img-29.jpeg](images/7ef1bc2adaaf4cf5.png)"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 1282,
      "preview": "--- page 50 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring Long Term PN",
      "line": 1284
    },
    {
      "type": "text",
      "section": "Monitoring Long Term PN",
      "line": 1286,
      "preview": "- Vitamins: A, E, 25-OHD every 3-6 months; B1, B6, B12, as appropriate"
    },
    {
      "type": "text",
      "section": "Monitoring Long Term PN",
      "line": 1287,
      "preview": "- Consider carnitine"
    },
    {
      "type": "text",
      "section": "Monitoring Long Term PN",
      "line": 1288,
      "preview": "- Trace elements: plasma $\\mathrm{Zn}, \\mathrm{Cu}, \\mathrm{Se}$, manganese (if on multitrace), urin"
    },
    {
      "type": "text",
      "section": "Monitoring Long Term PN",
      "line": 1289,
      "preview": "- Essential fatty acid panel when deficiency suspected or using newer lipid sources"
    },
    {
      "type": "text",
      "section": "Monitoring Long Term PN",
      "line": 1290,
      "preview": "- Monitor for iron deficiency (no iron in PN)"
    },
    {
      "type": "text",
      "section": "Monitoring Long Term PN",
      "line": 1291,
      "preview": "- Nutrient levels should be obtained when patients uninfected and need to be interpreted in clinical"
    },
    {
      "type": "text",
      "section": "Monitoring Long Term PN",
      "line": 1293,
      "preview": "--- page 51 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1295
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1297,
      "preview": "According to the FDA Drug Shortage web site the following PN components are considered in short supp"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1298,
      "preview": "Calcium gluconate injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1299,
      "preview": "Cyanocobalamin (Vitamin B12) injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1300,
      "preview": "Dextrose injection, 70\\%"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1301,
      "preview": "Magnesium sulfate injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1302,
      "preview": "Multi-vitamin infusion (adult and pediatric)"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1303,
      "preview": "Phosphate (Glycophos) injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1304,
      "preview": "Potassium chloride injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1305,
      "preview": "Selenium injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1306,
      "preview": "Sodium chloride $23.4 \\%$ injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1307,
      "preview": "Sodium phosphate injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1308,
      "preview": "Sterile water for injection solutions"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1309,
      "preview": "Trace elements (adult, pediatric and neonate)"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1310,
      "preview": "Zinc injection"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1311,
      "preview": "https://www.nutritioncare.org/News/Product_Shortages/Parenteral_Nutrition_Component_Shortages_Update"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1313,
      "preview": "--- page 52 ---"
    },
    {
      "type": "image",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1315,
      "content": "![img-30.jpeg](images/bf61d2f275fad985.png)"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1317,
      "preview": "**Fig. 1.** Amino acid effect on the solubility of Ca and P in a standard PN solution."
    },
    {
      "type": "image",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1319,
      "content": "![img-31.jpeg](images/fb48b6bcfed1815d.png)"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1321,
      "preview": "--- page 53 ---"
    },
    {
      "type": "image",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1323,
      "content": "![img-32.jpeg](images/30b80e52c496f1b4.png)"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1325,
      "preview": "Stanford"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1326,
      "preview": "Children's Health"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1327,
      "preview": "Lucile Packard"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1328,
      "preview": "Children's Hospital"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1329,
      "preview": "Stanford"
    },
    {
      "type": "image",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1331,
      "content": "![img-33.jpeg](images/574b4440fe19252d.png)"
    },
    {
      "type": "image",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1333,
      "content": "![img-34.jpeg](images/511aea30e963e2c5.png)"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition Component Shortages Update",
      "line": 1335,
      "preview": "--- page 54 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Role of Lipid Emulsions in Cholestasis Associated with Long Term PN in Children",
      "line": 1337
    },
    {
      "type": "text",
      "section": "Role of Lipid Emulsions in Cholestasis Associated with Long Term PN in Children",
      "line": 1339,
      "preview": "- Phytosterols contained in lipid emulsions may have a deleterious effect on biliary secretion."
    },
    {
      "type": "text",
      "section": "Role of Lipid Emulsions in Cholestasis Associated with Long Term PN in Children",
      "line": 1341,
      "preview": "--- page 55 ---"
    },
    {
      "type": "image",
      "section": "Role of Lipid Emulsions in Cholestasis Associated with Long Term PN in Children",
      "line": 1343,
      "content": "![img-35.jpeg](images/09f455f093741cc5.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Role of phytosterols",
      "line": 1345
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1347,
      "preview": "|  1800 | 1491  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1348,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1349,
      "preview": "|  1600 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1350,
      "preview": "|  1400 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1351,
      "preview": "|  1200 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1352,
      "preview": "|  1000 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1353,
      "preview": "|  800 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1354,
      "preview": "|  600 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1355,
      "preview": "|  400 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1356,
      "preview": "|  200 |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1357,
      "preview": "|  0 |   |"
    },
    {
      "type": "text",
      "section": "Role of phytosterols",
      "line": 1359,
      "preview": "**controls** **mild liver dysfunction** **severe liver dysfunction**"
    },
    {
      "type": "text",
      "section": "Role of phytosterols",
      "line": 1361,
      "preview": "Iyer KR, Spitz L, Clayton P. BAPS prize lecture: New insight into mechanisms of parenteral nutrition"
    },
    {
      "type": "image",
      "section": "Role of phytosterols",
      "line": 1363,
      "content": "![img-36.jpeg](images/1b427f8cbfc6ccb2.png)"
    },
    {
      "type": "text",
      "section": "Role of phytosterols",
      "line": 1365,
      "preview": "--- page 56 ---"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1367,
      "preview": "|   | Intralipid ${ }^{\\text {\u00ae }}$ | Omegaven ${ }^{\\text {\u00ae }}$ | SMOF $^{\\text {\u00ae }}$  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1368,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1369,
      "preview": "|  Vitamin E (mg/L) | 38 | 250 | 200  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1370,
      "preview": "|  Phytosterols (mg/L) | 343 | 0 | 48  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1371,
      "preview": "|  Oil Source |  |  |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1372,
      "preview": "|  Soybean oil \\% | 100 | 0 | 30  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1373,
      "preview": "|  Fish oil \\% | 0 | 100 | 15  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1374,
      "preview": "|  Coconut oil \\% | 0 | 0 | 30  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1375,
      "preview": "|  Olive oil \\% | 0 | 0 | 25  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1376,
      "preview": "|  Fat Composition |  |  |   |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1377,
      "preview": "|  Linoleic acid ( $\\mathrm{g} / 100 \\mathrm{cc}$ ) | 10 | $0.1-0.7$ | 2.85  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1378,
      "preview": "|  Arachidonic acid ( $\\mathrm{g} / 100 \\mathrm{cc}$ ) | 0 | $0.1-0.4$ | 0.05  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1379,
      "preview": "|  $\\alpha$-Linolenic acid ( $\\mathrm{g} / 100 \\mathrm{cc}$ ) | 0.9 | $<0.2$ | 0.275  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1380,
      "preview": "|  Eicosapentaenoic acid ( $\\mathrm{g} / 100 \\mathrm{cc}$ ) | 0 | $1.28-2.82$ | 0.25  |"
    },
    {
      "type": "table",
      "section": "Role of phytosterols",
      "line": 1381,
      "preview": "|  Docosahexaenoic acid ( $\\mathrm{g} / 100 \\mathrm{cc}$ ) | 0 | $1.44-3.09$ | 0.05  |"
    },
    {
      "type": "text",
      "section": "Role of phytosterols",
      "line": 1383,
      "preview": "Intralipid Dose: $0.5-3 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ Omegaven Dose: $1 \\mathrm{~g} / \\mat"
    },
    {
      "type": "text",
      "section": "Role of phytosterols",
      "line": 1385,
      "preview": "--- page 57 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "IV Lipid Emulsions",
      "line": 1387
    },
    {
      "type": "text",
      "section": "IV Lipid Emulsions",
      "line": 1389,
      "preview": "- Children requiring prolonged PN may receive"
    },
    {
      "type": "text",
      "section": "IV Lipid Emulsions",
      "line": 1390,
      "preview": "- Soybean oil (Intralipid\u00ae/IL/SOLE)"
    },
    {
      "type": "text",
      "section": "IV Lipid Emulsions",
      "line": 1391,
      "preview": "- Composite lipid emulsion (SMOFlipid\u00ae/CLE) FDA approved 3/2022"
    },
    {
      "type": "text",
      "section": "IV Lipid Emulsions",
      "line": 1392,
      "preview": "- Fish oil (Omegaven\u00ae/OM/FOLE) FDA approved 7/2018"
    },
    {
      "type": "text",
      "section": "IV Lipid Emulsions",
      "line": 1393,
      "preview": "- IL restriction is a popular method of reducing the risk of intestinal failure associated liver dis"
    },
    {
      "type": "text",
      "section": "IV Lipid Emulsions",
      "line": 1394,
      "preview": "- Essential fatty acid deficiency (EFAD) can occur with restricted protocols ${ }^{[1,3]}$"
    },
    {
      "type": "text",
      "section": "IV Lipid Emulsions",
      "line": 1396,
      "preview": "--- page 58 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Low Dose Lipid Treatment Study",
      "line": 1398
    },
    {
      "type": "heading",
      "level": 2,
      "section": "(Prospective with Historical Controls)",
      "line": 1400
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Eligibility Criteria:",
      "line": 1402
    },
    {
      "type": "text",
      "section": "Eligibility Criteria:",
      "line": 1403,
      "preview": "- \u2265 2 weeks"
    },
    {
      "type": "text",
      "section": "Eligibility Criteria:",
      "line": 1404,
      "preview": "- Direct bilirubin \u2265 2.5 mg/dL or total bilirubin \u2265 5 mg/dL"
    },
    {
      "type": "text",
      "section": "Eligibility Criteria:",
      "line": 1406,
      "preview": "**Intervention:** 1 g/kg/d 2 x/week"
    },
    {
      "type": "image",
      "section": "Eligibility Criteria:",
      "line": 1408,
      "content": "![img-37.jpeg](images/77bc20debd8a1561.png)"
    },
    {
      "type": "text",
      "section": "Eligibility Criteria:",
      "line": 1410,
      "preview": "Total bilirubin concentrations decreased in the low dose group vs. standard dose group (-0.73 mg/dL/"
    },
    {
      "type": "image",
      "section": "Eligibility Criteria:",
      "line": 1412,
      "content": "![img-38.jpeg](images/ab79ac111597d7f4.png)"
    },
    {
      "type": "text",
      "section": "Eligibility Criteria:",
      "line": 1414,
      "preview": "Cober MP, et al. Jour of Pediatr, 2011."
    },
    {
      "type": "text",
      "section": "Eligibility Criteria:",
      "line": 1416,
      "preview": "--- page 59 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Fish oil",
      "line": 1418
    },
    {
      "type": "text",
      "section": "Fish oil",
      "line": 1420,
      "preview": "- **EPA (20: 5n-3)**"
    },
    {
      "type": "text",
      "section": "Fish oil",
      "line": 1421,
      "preview": "- **DHAA (22: 6n-3)**"
    },
    {
      "type": "text",
      "section": "Fish oil",
      "line": 1423,
      "preview": "- **Decrease inflammation**"
    },
    {
      "type": "text",
      "section": "Fish oil",
      "line": 1424,
      "preview": "- Increase antioxidant activity"
    },
    {
      "type": "text",
      "section": "Fish oil",
      "line": 1425,
      "preview": "- No phytosterols"
    },
    {
      "type": "text",
      "section": "Fish oil",
      "line": 1426,
      "preview": "- Increase bile flow"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Soybean oil",
      "line": 1428
    },
    {
      "type": "text",
      "section": "Soybean oil",
      "line": 1430,
      "preview": "- **ARA (20: 4n-6)**"
    },
    {
      "type": "text",
      "section": "Soybean oil",
      "line": 1432,
      "preview": "- **Increase inflammation**"
    },
    {
      "type": "text",
      "section": "Soybean oil",
      "line": 1433,
      "preview": "- Decrease antioxidant activity"
    },
    {
      "type": "text",
      "section": "Soybean oil",
      "line": 1434,
      "preview": "- Phytosterols present"
    },
    {
      "type": "text",
      "section": "Soybean oil",
      "line": 1435,
      "preview": "- Decrease bile flow"
    },
    {
      "type": "image",
      "section": "Soybean oil",
      "line": 1437,
      "content": "![img-39.jpeg](images/349afdbed5f60574.png)"
    },
    {
      "type": "text",
      "section": "Soybean oil",
      "line": 1439,
      "preview": "--- page 60 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Omegaven\u00ae for TPNAC: The Boston Experience",
      "line": 1441
    },
    {
      "type": "image",
      "section": "Omegaven\u00ae for TPNAC: The Boston Experience",
      "line": 1443,
      "content": "![img-40.jpeg](images/76e3c73c9484cf46.png)"
    },
    {
      "type": "text",
      "section": "Omegaven\u00ae for TPNAC: The Boston Experience",
      "line": 1445,
      "preview": "*Case 2:* Fmr 25 week infant with atrial perforation, intestinal perforation, multiple intestinal su"
    },
    {
      "type": "text",
      "section": "Omegaven\u00ae for TPNAC: The Boston Experience",
      "line": 1447,
      "preview": "(KM Gura *et al. Pediatrics*, Vol 118, no 1, July 2006)"
    },
    {
      "type": "text",
      "section": "Omegaven\u00ae for TPNAC: The Boston Experience",
      "line": 1449,
      "preview": "--- page 61 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Fish Oil Intravenous Emulsion",
      "line": 1451
    },
    {
      "type": "text",
      "section": "Fish Oil Intravenous Emulsion",
      "line": 1453,
      "preview": "- Open-labeled trial: fish oil-based IV lipid in 42 infants with SBS and TPN who developed cholestas"
    },
    {
      "type": "text",
      "section": "Fish Oil Intravenous Emulsion",
      "line": 1454,
      "preview": "- Compared to contemporary cohort 49 infants with SBS and cholestasis with TPN using IV soybean lipi"
    },
    {
      "type": "image",
      "section": "Fish Oil Intravenous Emulsion",
      "line": 1456,
      "content": "![img-41.jpeg](images/ddb0e6253f1d98a5.png)"
    },
    {
      "type": "text",
      "section": "Fish Oil Intravenous Emulsion",
      "line": 1458,
      "preview": "*Puder M et al. Ann Surg 2009;250:395*"
    },
    {
      "type": "text",
      "section": "Fish Oil Intravenous Emulsion",
      "line": 1460,
      "preview": "--- page 62 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SMOFlipid\u00ae",
      "line": 1462
    },
    {
      "type": "text",
      "section": "SMOFlipid\u00ae",
      "line": 1464,
      "preview": "- Balanced 20% Lipid Emulsion"
    },
    {
      "type": "text",
      "section": "SMOFlipid\u00ae",
      "line": 1465,
      "preview": "- Soybean Oil"
    },
    {
      "type": "text",
      "section": "SMOFlipid\u00ae",
      "line": 1466,
      "preview": "- Medium Chain Triglycerides"
    },
    {
      "type": "text",
      "section": "SMOFlipid\u00ae",
      "line": 1467,
      "preview": "- Olive Oil"
    },
    {
      "type": "text",
      "section": "SMOFlipid\u00ae",
      "line": 1468,
      "preview": "- Fish Oil"
    },
    {
      "type": "text",
      "section": "SMOFlipid\u00ae",
      "line": 1469,
      "preview": "- alpha-tocopherol"
    },
    {
      "type": "image",
      "section": "SMOFlipid\u00ae",
      "line": 1471,
      "content": "![img-42.jpeg](images/59abc534ad9969d1.png)"
    },
    {
      "type": "image",
      "section": "SMOFlipid\u00ae",
      "line": 1473,
      "content": "![img-43.jpeg](images/2e25b73a14763f92.png)"
    },
    {
      "type": "text",
      "section": "SMOFlipid\u00ae",
      "line": 1475,
      "preview": "--- page 63 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Preventing the Progression of Intestinal Failure\u2014Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid",
      "line": 1477
    },
    {
      "type": "text",
      "section": "Preventing the Progression of Intestinal Failure\u2014Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid",
      "line": 1479,
      "preview": "**Ivan R. Diamond, MD\u00b9; Robert C. Grant, MD\u00b9; Paul B. Pencharz, MD\u00b9; Nicole de Silva, RN\u00b9; Brian M. "
    },
    {
      "type": "image",
      "section": "Preventing the Progression of Intestinal Failure\u2014Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid",
      "line": 1481,
      "content": "![img-44.jpeg](images/50d24b178a9815a5.png)"
    },
    {
      "type": "text",
      "section": "Preventing the Progression of Intestinal Failure\u2014Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid",
      "line": 1483,
      "preview": "**Conjugated Bilirubin**"
    },
    {
      "type": "image",
      "section": "Preventing the Progression of Intestinal Failure\u2014Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid",
      "line": 1485,
      "content": "![img-45.jpeg](images/51a5148e6ee12393.png)"
    },
    {
      "type": "text",
      "section": "Preventing the Progression of Intestinal Failure\u2014Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid",
      "line": 1487,
      "preview": "--- page 64 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy",
      "line": 1489
    },
    {
      "type": "text",
      "section": "Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy",
      "line": 1491,
      "preview": "Lee et al. *JPEN.* 2016 Mar;40(3):437-40"
    },
    {
      "type": "text",
      "section": "Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy",
      "line": 1493,
      "preview": "**Figure 1.** Changes in direct bilirubin levels during treatment with Omegaven in case 1 (A) and ca"
    },
    {
      "type": "image",
      "section": "Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy",
      "line": 1495,
      "content": "![img-46.jpeg](images/98c49c36cae3b433.png)"
    },
    {
      "type": "image",
      "section": "Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy",
      "line": 1497,
      "content": "![img-47.jpeg](images/577cfe98b9ead75b.png)"
    },
    {
      "type": "text",
      "section": "Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy",
      "line": 1499,
      "preview": "--- page 65 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Omegaven 1g/kg/day",
      "line": 1501
    },
    {
      "type": "image",
      "section": "Omegaven 1g/kg/day",
      "line": 1503,
      "content": "![img-48.jpeg](images/20ca9d1988b71090.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Intralipid 1g/kg + Omegaven 1g/kg",
      "line": 1505
    },
    {
      "type": "image",
      "section": "Intralipid 1g/kg + Omegaven 1g/kg",
      "line": 1507,
      "content": "![img-49.jpeg](images/0321e5e5dd88541a.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Liposyn Minimization, 1g/kg twice weekly",
      "line": 1509
    },
    {
      "type": "image",
      "section": "Liposyn Minimization, 1g/kg twice weekly",
      "line": 1511,
      "content": "![img-50.jpeg](images/aff0a955e81e0dbf.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SMOFlipid 2g/kg/d",
      "line": 1513
    },
    {
      "type": "image",
      "section": "SMOFlipid 2g/kg/d",
      "line": 1515,
      "content": "![img-51.jpeg](images/cec198c396f275ec.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Intafilipid MEDICINE",
      "line": 1517
    },
    {
      "type": "text",
      "section": "Intafilipid MEDICINE",
      "line": 1519,
      "preview": "*Gura, 2008*"
    },
    {
      "type": "text",
      "section": "Intafilipid MEDICINE",
      "line": 1521,
      "preview": "*Diamond, 2009*"
    },
    {
      "type": "text",
      "section": "Intafilipid MEDICINE",
      "line": 1523,
      "preview": "--- page 66 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1525
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1527,
      "preview": "- FDA approved in 2016 for adults in US"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1528,
      "preview": "- Approved in Europe in 2000 (adults) \\& 2009 (children)"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1529,
      "preview": "- Approved in Canada in 2013"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1530,
      "preview": "- FDA approved for children in US in March 2022"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1531,
      "preview": "- Reported to be safe in infants and children in Europe when used short-term ${ }^{[1,2]}$"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1532,
      "preview": "- In the US, off-label in infants/children, often dosed using foreign package insert recommendations"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1534,
      "preview": "Theoretical benefit of reduced hypertriglyceridemia, improved inflammatory cascade, and decreased ri"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1536,
      "preview": "Boston Children's Hospital"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1537,
      "preview": "Until every child is well"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1539,
      "preview": "1. Goulet, O., et al. JPEN J Parenter Enteral Nutr, 2010"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1540,
      "preview": "2. Tomsits, E., et al. J Pediatr Gastroenterol Nutr, 2010"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1541,
      "preview": "3. Mundi, M.S., R. Martindale, and R.T. Hurt, JPEN, 2017"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$",
      "line": 1543,
      "preview": "--- page 67 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1545
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1547,
      "preview": "Table 13. Pediatric dosing for Smoflipid"
    },
    {
      "type": "table",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1549,
      "preview": "|  Patients | Initiation (g/kg/day) | Advance By (g/kg/day) | Goal Dose (g/kg/day)  |"
    },
    {
      "type": "table",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1550,
      "preview": "| --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1551,
      "preview": "|  Preterm Infants | $0.5-1$ | $0.5-1$ | 3  |"
    },
    {
      "type": "table",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1552,
      "preview": "|  Term Infants | $0.5-1$ | $0.5-1$ | $2.5-3$  |"
    },
    {
      "type": "table",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1553,
      "preview": "|  Children (1-10y) | $1-2$ | $0.5-1$ | $2-2.5$  |"
    },
    {
      "type": "table",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1554,
      "preview": "|  Adolescents | 1 | 1 | 2  |"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1556,
      "preview": "A Dossier of Clinical Evidence in Support of Formulary Consideration Fresenius Kabi AG 2016"
    },
    {
      "type": "text",
      "section": "SMOFlipid ${ }^{\\circledR}$ Dosing",
      "line": 1558,
      "preview": "--- page 68 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SMOF Guidelines",
      "line": 1560
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1562,
      "preview": "- SMOF (FDA approved for children, March 2022)"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1563,
      "preview": "- Must meet at least ONE of the following criteria for initiation:"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1565,
      "preview": "1. Neonates with birthweight $<1 \\mathrm{~kg}$"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1566,
      "preview": "2. Infants $<12$ months requiring or anticipating prolonged PN use $>21$ days"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1567,
      "preview": "3. Home PN patients with pre-existing SMOF usage"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1568,
      "preview": "4. Anticipated PN use for longer than 21 days, and the presence of one of the following:"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1569,
      "preview": "a. Intestinal failure (short bowel syndrome, chronic intestinal pseudo-obstruction, congenital diarr"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1570,
      "preview": "b. Elevated LFTs"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1571,
      "preview": "c. Elevated direct bilirubin"
    },
    {
      "type": "text",
      "section": "SMOF Guidelines",
      "line": 1573,
      "preview": "--- page 69 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Omegaven ${ }^{\\circledR}$",
      "line": 1575
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$",
      "line": 1577,
      "preview": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/0210589s000lbledt.pdf"
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$",
      "line": 1579,
      "preview": "- In July 2018, the US FDA approved Omegaven ${ }^{\\circledR}$ as an alternative source of intraveno"
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$",
      "line": 1580,
      "preview": "- 1 gram $/ \\mathrm{kg} / \\mathrm{d}$ with the $10 \\%$ emulsion"
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$",
      "line": 1582,
      "preview": "--- page 70 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Omegaven ${ }^{\\circledR}$ Guidelines",
      "line": 1584
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$ Guidelines",
      "line": 1586,
      "preview": "- \"Initiate dosing in PN-dependent pediatric patients as soon as direct (or conjugated) bilirubin le"
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$ Guidelines",
      "line": 1587,
      "preview": "- \"Omegaven is not indicated for the prevention of PNAC\""
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$ Guidelines",
      "line": 1588,
      "preview": "- LPCHS policy recommends against starting Omegaven in infants < 2 wks old with cholestasis (PNAC pr"
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$ Guidelines",
      "line": 1589,
      "preview": "- Prior to starting Omegaven ${ }^{\\circledR}$, make sure the direct bilirubin $\\geq 2 \\mathrm{mg} /"
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$ Guidelines",
      "line": 1590,
      "preview": "- GI consult is required to approve use"
    },
    {
      "type": "text",
      "section": "Omegaven ${ }^{\\circledR}$ Guidelines",
      "line": 1592,
      "preview": "--- page 71 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1594
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1596,
      "preview": "- Child ID, MDs, allergies, diagnosis, line info"
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1597,
      "preview": "- Instructions for parents (English or Spanish)"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1599,
      "preview": "|  Name: | DOB: / / Issued: / /  |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1600,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1601,
      "preview": "|  Primary MD: | Phone:  |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1602,
      "preview": "|  Subspecialty MD: | Phone:  |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1603,
      "preview": "|  Drug allergies: |   |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1604,
      "preview": "|  Primary diagnosis: |   |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1605,
      "preview": "|  Reason for line: TPN / | Placement date: / /  |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1606,
      "preview": "|  Line type: Broviac / Hickman / Port / PICC / |   |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1607,
      "preview": "|  Size (Fr): Brand: | Cat #:  |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1608,
      "preview": "|  Material: Silicone / Polyurethane / | Ok for EtOH locks? Y / N  |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1609,
      "preview": "|  For Parents: If patient has fever over 100.4F or 38.0C |   |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1610,
      "preview": "|  - GO TO NEAREST ED, Urgent Care, or Primary MD |   |"
    },
    {
      "type": "table",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1611,
      "preview": "|  - CALL PEDS GI at Stanford: 650-723-5070 or 650-723-6661 |   |"
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1613,
      "preview": "--- page 72 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1615
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1617,
      "preview": "- Rule-out sepsis protocol *checklist* for MDs"
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1619,
      "preview": "**For MDs:** If patient presents to an ED or urgent care facility with T>100.4F or >38.0C:"
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1621,
      "preview": "- Please obtain cath UA, UCx, and blood culture, CBCD, CRP, COAG panel (if worried about DIC), +/- C"
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1622,
      "preview": "- Start empiric broad spectrum antibiotics (vancomycin/ceftazidime) through central line unless othe"
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1623,
      "preview": "- CALL PEDS GI at Stanford: 650-723-5070 (transfer center) or 650-723-6661 (peds GI fellow on call) "
    },
    {
      "type": "image",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1625,
      "content": "![img-52.jpeg](images/7a16165fdfa9d2c2.png)"
    },
    {
      "type": "text",
      "section": "Our Intervention: A \"Central Line Care Card\"",
      "line": 1627,
      "preview": "--- page 73 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Causes of Catheter Occlusion",
      "line": 1629
    },
    {
      "type": "text",
      "section": "Causes of Catheter Occlusion",
      "line": 1631,
      "preview": "- Clot or thrombus"
    },
    {
      "type": "text",
      "section": "Causes of Catheter Occlusion",
      "line": 1632,
      "preview": "- Fibrin deposition"
    },
    {
      "type": "text",
      "section": "Causes of Catheter Occlusion",
      "line": 1633,
      "preview": "- Fat deposition"
    },
    {
      "type": "text",
      "section": "Causes of Catheter Occlusion",
      "line": 1634,
      "preview": "- Calcium-phosphorus precipitation"
    },
    {
      "type": "text",
      "section": "Causes of Catheter Occlusion",
      "line": 1635,
      "preview": "- Drug precipitation"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Mechanical Causes",
      "line": 1638
    },
    {
      "type": "text",
      "section": "Mechanical Causes",
      "line": 1640,
      "preview": "- Kinking of the catheter"
    },
    {
      "type": "text",
      "section": "Mechanical Causes",
      "line": 1641,
      "preview": "- Catheter tip against venous wall"
    },
    {
      "type": "text",
      "section": "Mechanical Causes",
      "line": 1642,
      "preview": "- Excessively tight suture"
    },
    {
      "type": "text",
      "section": "Mechanical Causes",
      "line": 1644,
      "preview": "--- page 74 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Causes and Management of Catheter Occlusion",
      "line": 1646
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Cause",
      "line": 1648
    },
    {
      "type": "text",
      "section": "Cause",
      "line": 1650,
      "preview": "- Clot or thrombus"
    },
    {
      "type": "text",
      "section": "Cause",
      "line": 1651,
      "preview": "- Fat deposition"
    },
    {
      "type": "text",
      "section": "Cause",
      "line": 1652,
      "preview": "- Calcium-phosphorus deposition"
    },
    {
      "type": "text",
      "section": "Cause",
      "line": 1653,
      "preview": "- Drug precipitation"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Management",
      "line": 1656
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1658,
      "preview": "- t-PA (Alteplase)"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1659,
      "preview": "- $70 \\%$ ethanol"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1660,
      "preview": "- 0.1 N Hydrochloric acid*"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1661,
      "preview": "- 0.1 N Hydrochloric acid* or 0.1 N NaOH"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1662,
      "preview": "* Now we use L-cysteine I.V."
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1664,
      "preview": "--- page 75 ---"
    },
    {
      "type": "image",
      "section": "Management",
      "line": 1666,
      "content": "![img-53.jpeg](images/94f60fe29acd8bee.png)"
    },
    {
      "type": "image",
      "section": "Management",
      "line": 1668,
      "content": "![img-54.jpeg](images/7fd611fa0c1d476a.png)"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1670,
      "preview": "**Stanford**"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1672,
      "preview": "*Lugile Packard*"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1674,
      "preview": "*Children's Health*"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1676,
      "preview": "*Children's Hospital*"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1678,
      "preview": "*Stanford*"
    },
    {
      "type": "image",
      "section": "Management",
      "line": 1680,
      "content": "![img-55.jpeg](images/4f0b4a16a65c2aa8.png)"
    },
    {
      "type": "text",
      "section": "Management",
      "line": 1682,
      "preview": "--- page 76 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "The Subs are Back!",
      "line": 1684
    },
    {
      "type": "image",
      "section": "The Subs are Back!",
      "line": 1686,
      "content": "![img-56.jpeg](images/f5bbe91c4aa68f0d.png)"
    },
    {
      "type": "text",
      "section": "The Subs are Back!",
      "line": 1688,
      "preview": "--- page 77 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Board Question",
      "line": 1690
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1692,
      "preview": "Children on parenteral nutrition are at risk for zinc deficiency, which may manifest as which of the"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1693,
      "preview": "A. Constipation"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1694,
      "preview": "B. Poor wound healing and low alkaline phosphatase"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1695,
      "preview": "C. Thrombocytopenia"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1696,
      "preview": "D. Psychosis"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1698,
      "preview": "Answer: B. Poor wound healing and low alkaline phosphatase. Zinc is a mineral that is important for "
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1700,
      "preview": "--- page 78 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Board Question",
      "line": 1702
    },
    {
      "type": "image",
      "section": "Board Question",
      "line": 1704,
      "content": "![img-57.jpeg](images/951e266d577e0429.png)"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1706,
      "preview": "- Can cause"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1707,
      "preview": "- Decreased growth"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1708,
      "preview": "- Skin and hair changes"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1709,
      "preview": "- Poor wound healing"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1710,
      "preview": "- Alterations in platelet function"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1711,
      "preview": "- Increased susceptibility to infection"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1713,
      "preview": "- How does one test for essential fatty acid deficiency?"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1714,
      "preview": "- Serum triene:tetraene ratio"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1715,
      "preview": "- What ratio is thought to be EFA sufficient?"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1716,
      "preview": "- Serum triene:tetraene ratio <0.2 is considered to be EFA sufficient"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1718,
      "preview": "*Source: Stanford Childrens Health*"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1720,
      "preview": "*Mediator: Lucile Packard*"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1722,
      "preview": "*Mediator: Children's Hospital*"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1724,
      "preview": "*Mediator: Stanford Childrens Health*"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1726,
      "preview": "--- page 79 ---"
    },
    {
      "type": "image",
      "section": "Board Question",
      "line": 1728,
      "content": "![img-58.jpeg](images/eb3dd0f4b6a0b5ce.png)"
    },
    {
      "type": "image",
      "section": "Board Question",
      "line": 1730,
      "content": "![img-59.jpeg](images/d55e0356d1b7ef70.png)"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1732,
      "preview": "**Stanford Children's Health**"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1734,
      "preview": "**Lucile Packard Children's Hospital Stanford**"
    },
    {
      "type": "text",
      "section": "Board Question",
      "line": 1736,
      "preview": "--- page 80 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Biofilm impenetrable to host immune response",
      "line": 1738
    },
    {
      "type": "heading",
      "level": 2,
      "section": "CATHETER SURFACE",
      "line": 1740
    },
    {
      "type": "heading",
      "level": 3,
      "section": "Biofilm impenetrable to antibiotics",
      "line": 1742
    },
    {
      "type": "text",
      "section": "Biofilm impenetrable to antibiotics",
      "line": 1744,
      "preview": "1. **Organic layer attachment**"
    },
    {
      "type": "text",
      "section": "Biofilm impenetrable to antibiotics",
      "line": 1745,
      "preview": "2. **Bacterial colonisation & multiplication**"
    },
    {
      "type": "text",
      "section": "Biofilm impenetrable to antibiotics",
      "line": 1746,
      "preview": "3. **Formation of protective exopolymer saccharides**"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "4. Dispersal of Biofilm Matrix",
      "line": 1748
    },
    {
      "type": "image",
      "section": "4. Dispersal of Biofilm Matrix",
      "line": 1750,
      "content": "![img-60.jpeg](images/c1e8e6797276db6f.png)"
    },
    {
      "type": "text",
      "section": "4. Dispersal of Biofilm Matrix",
      "line": 1752,
      "preview": "**Stanford MEDICINE**"
    },
    {
      "type": "text",
      "section": "4. Dispersal of Biofilm Matrix",
      "line": 1754,
      "preview": "--- page 81 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Ethanol Lock",
      "line": 1756
    },
    {
      "type": "text",
      "section": "Ethanol Lock",
      "line": 1758,
      "preview": "- Ethanol is bactericidal and fungicidal"
    },
    {
      "type": "text",
      "section": "Ethanol Lock",
      "line": 1759,
      "preview": "- Nonspecifically denatures cell membrane proteins"
    },
    {
      "type": "text",
      "section": "Ethanol Lock",
      "line": 1760,
      "preview": "- Inhibit bacterial growth and penetrates bacterial biofilm within the line"
    },
    {
      "type": "text",
      "section": "Ethanol Lock",
      "line": 1761,
      "preview": "- Improves clearance of line infection"
    },
    {
      "type": "text",
      "section": "Ethanol Lock",
      "line": 1762,
      "preview": "- May save the line from replacement"
    },
    {
      "type": "text",
      "section": "Ethanol Lock",
      "line": 1764,
      "preview": "--- page 82 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TPN",
      "line": 1766
    },
    {
      "type": "text",
      "section": "TPN",
      "line": 1768,
      "preview": "--- page 83 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Ethanol-lock for catheter salvage",
      "line": 1770
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1772,
      "preview": "- 40 children/51 CVC-related infections"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1773,
      "preview": "- EtOH 70\\%: 0.8 - 1.4 mL for 12-24 hr, then withdrawn"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1774,
      "preview": "- Catheters removed: 0"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1776,
      "preview": "Onland W, et al. Arch Pediatr Adolesc Med. 2005; 160: 1049-1053."
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1778,
      "preview": "--- page 84 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Ethanol-lock for catheter salvage",
      "line": 1780
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1782,
      "preview": "- After EtOH withdrawn, isotonic saline flush"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1783,
      "preview": "- Repeat EtOH for 5 consecutive days"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1784,
      "preview": "- Separate peripheral line for IV Abx."
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1785,
      "preview": "- With double lumen catheters ethanol into 1 lumen for 24 hrs., while the other lumen used for infus"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1786,
      "preview": "- Both lumens were alternately treated for 10 days"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1788,
      "preview": "Onland W, et al. Arch Pediatr Adolesc Med. 2005; 160: 1049-1053."
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1790,
      "preview": "--- page 85 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Ethanol-lock for catheter salvage",
      "line": 1792
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1794,
      "preview": "- Relapse: $12 \\%$"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1795,
      "preview": "- $75 \\%$ of polymicrobial isolates: no recurrence"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1796,
      "preview": "- $94 \\%$ of monomicrobial isolates successfully treated"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1797,
      "preview": "- The treatments of 2 yeast isolates were also successful"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1799,
      "preview": "Onland W, et al. Arch Pediatr Adolesc Med. 2005; 160: 1049-1053."
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1801,
      "preview": "--- page 86 ---"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1803,
      "preview": "40S Journal of Parenteral and Enteral Nutrition / Vol. 36, Suppl. 1, January 2012"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1805,
      "preview": "Table 1. Ethanol Lock Therapy in Intestinal Failure"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1807,
      "preview": "|  Author | Year | N | Pediatric or Adult | Catheter-Related Bloodstream Infections Rate ${ }^{a}$ |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1808,
      "preview": "| --- | --- | --- | --- | --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1809,
      "preview": "|   |  |  |  | Pre-ELT | Post-ELT |  |  |   |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1810,
      "preview": "|  Opilla et al ${ }^{61, b}$ | 2007 | 9 | Adult | 8.3 | 2.7 | $1-7$ | $2-4$ | $25-70$  |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1811,
      "preview": "|  Mouw et al ${ }^{59}$ | 2008 | 5 | Pediatric | 11.5 | 2.1 | 7 | $4-14$ | 70  |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1812,
      "preview": "|  Jones et al ${ }^{60}$ | 2010 | 23 | Pediatric | 9.9 | 2.1 | 3 | $\\geq 4$ | 70  |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1813,
      "preview": "|  Cober et al ${ }^{62}$ | 2011 | 15 | Pediatric | 8.0 | 1.3 | 7 | $\\geq 2$ | 70  |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1814,
      "preview": "|  Wales et al ${ }^{63}$ | 2011 | 10 | Pediatric | 10.2 | 0.9 | 7 | $\\geq 4$ | 70  |"
    },
    {
      "type": "table",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1815,
      "preview": "|  Pieroni et al ${ }^{64}$ | 2011 | 13 | Pediatric | 14 | 2.8 | 1 | 2 | 70  |"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1817,
      "preview": "ELT, ethanol lock therapy. ${ }^{a}$ Per 1000 catheter days. ${ }^{\\text {b }}$ Included home parent"
    },
    {
      "type": "text",
      "section": "Ethanol-lock for catheter salvage",
      "line": 1819,
      "preview": "--- page 87 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Ethanol Lock Data",
      "line": 1821
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Evaluation of Ethanol Lock Therapy in Pediatric Patients on Long-Term TPN",
      "line": 1823
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pieroni et al",
      "line": 1825
    },
    {
      "type": "text",
      "section": "Pieroni et al",
      "line": 1827,
      "preview": "-Nutr Clin Practice 2013; 28: 226-231."
    },
    {
      "type": "text",
      "section": "Pieroni et al",
      "line": 1829,
      "preview": "- 73\\% Reduction in CABSI's"
    },
    {
      "type": "text",
      "section": "Pieroni et al",
      "line": 1830,
      "preview": "- 77\\% Reduction in line replacements"
    },
    {
      "type": "text",
      "section": "Pieroni et al",
      "line": 1832,
      "preview": "--- page 88 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Results: Adverse Events",
      "line": 1834
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1836,
      "preview": "|  Source | Adverse Events (reported selectively for EL)  |"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1837,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1838,
      "preview": "|  Mouw, 2008 | No adverse events reported by parents or health care providers 1/10 CVC-related thro"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1839,
      "preview": "|   | 1/10 two episodes of culture negative disseminated intravascular coagulations (full recovery w"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1840,
      "preview": "|   | 1/10 Loss of line integrity  |"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1841,
      "preview": "|  Jones, 2010 | No adverse events  |"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1842,
      "preview": "|  Cober, 2010 | 1/15 deep vein thrombosis in the same leg as CVC  |"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1843,
      "preview": "|   | 3/15 families complained temporarily the difficulty of withdrawing the solution  |"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1844,
      "preview": "|   | 7/15 patients had twenty catheter leakages or disruptions (non-significantly different when co"
    },
    {
      "type": "table",
      "section": "Results: Adverse Events",
      "line": 1845,
      "preview": "|  Wales, 2011 | 2/10 CVC-related thrombus  |"
    },
    {
      "type": "text",
      "section": "Results: Adverse Events",
      "line": 1847,
      "preview": "--- page 89 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ECHINOCANDIN AND ETHANOL LOCK THERAPY TREATMENT OF FUNGAL CATHETER INFECTIONS",
      "line": 1849
    },
    {
      "type": "text",
      "section": "ECHINOCANDIN AND ETHANOL LOCK THERAPY TREATMENT OF FUNGAL CATHETER INFECTIONS",
      "line": 1851,
      "preview": "Kevin P. Pieroni, MD,* Colleen Nespor, RN, $\\dagger$<br>Robert L. Poole, PharmD, $\\dagger \\ddagger$ "
    },
    {
      "type": "text",
      "section": "ECHINOCANDIN AND ETHANOL LOCK THERAPY TREATMENT OF FUNGAL CATHETER INFECTIONS",
      "line": 1853,
      "preview": "Abstract: Ethanol lock therapy has been implemented to prevent infections of central venous catheter"
    },
    {
      "type": "text",
      "section": "ECHINOCANDIN AND ETHANOL LOCK THERAPY TREATMENT OF FUNGAL CATHETER INFECTIONS",
      "line": 1855,
      "preview": "--- page 90 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Questions?",
      "line": 1857
    },
    {
      "type": "image",
      "section": "Questions?",
      "line": 1859,
      "content": "![img-61.jpeg](images/a241a164696e5df0.png)"
    },
    {
      "type": "image",
      "section": "Questions?",
      "line": 1861,
      "content": "![img-62.jpeg](images/bb7b195d040bcb64.png)"
    },
    {
      "type": "image",
      "section": "Questions?",
      "line": 1863,
      "content": "![img-63.jpeg](images/8d39486b7a3c6a29.png)"
    }
  ],
  "images": [
    {
      "sha_name": "324b4d09d82fd0bd.png",
      "original_ref": "img-0.jpeg",
      "page": 1,
      "relative_path": "images/324b4d09d82fd0bd.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/324b4d09d82fd0bd.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "324b4d09d82fd0bd"
    },
    {
      "sha_name": "73c8a4bb07b608cf.png",
      "original_ref": "img-1.jpeg",
      "page": 4,
      "relative_path": "images/73c8a4bb07b608cf.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/73c8a4bb07b608cf.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "73c8a4bb07b608cf"
    },
    {
      "sha_name": "870d0b8684935159.png",
      "original_ref": "img-2.jpeg",
      "page": 4,
      "relative_path": "images/870d0b8684935159.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/870d0b8684935159.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "870d0b8684935159"
    },
    {
      "sha_name": "f013cf8fcfade536.png",
      "original_ref": "img-3.jpeg",
      "page": 5,
      "relative_path": "images/f013cf8fcfade536.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/f013cf8fcfade536.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "f013cf8fcfade536"
    },
    {
      "sha_name": "599bd64014fbc67c.png",
      "original_ref": "img-4.jpeg",
      "page": 6,
      "relative_path": "images/599bd64014fbc67c.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/599bd64014fbc67c.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "599bd64014fbc67c"
    },
    {
      "sha_name": "f32f4c27549af6ed.png",
      "original_ref": "img-5.jpeg",
      "page": 8,
      "relative_path": "images/f32f4c27549af6ed.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/f32f4c27549af6ed.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "f32f4c27549af6ed"
    },
    {
      "sha_name": "b47cebfa11ba4ff7.png",
      "original_ref": "img-6.jpeg",
      "page": 8,
      "relative_path": "images/b47cebfa11ba4ff7.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/b47cebfa11ba4ff7.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b47cebfa11ba4ff7"
    },
    {
      "sha_name": "5bb8c7bf2a4716a5.png",
      "original_ref": "img-7.jpeg",
      "page": 13,
      "relative_path": "images/5bb8c7bf2a4716a5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/5bb8c7bf2a4716a5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "5bb8c7bf2a4716a5"
    },
    {
      "sha_name": "bfb11d5ff61d0284.png",
      "original_ref": "img-8.jpeg",
      "page": 14,
      "relative_path": "images/bfb11d5ff61d0284.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/bfb11d5ff61d0284.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "bfb11d5ff61d0284"
    },
    {
      "sha_name": "909e5c78415a1be7.png",
      "original_ref": "img-9.jpeg",
      "page": 15,
      "relative_path": "images/909e5c78415a1be7.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/909e5c78415a1be7.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "909e5c78415a1be7"
    },
    {
      "sha_name": "be2e4b6763e9f1b1.png",
      "original_ref": "img-10.jpeg",
      "page": 15,
      "relative_path": "images/be2e4b6763e9f1b1.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/be2e4b6763e9f1b1.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "be2e4b6763e9f1b1"
    },
    {
      "sha_name": "1bc8d0dfa80f3cfa.png",
      "original_ref": "img-11.jpeg",
      "page": 15,
      "relative_path": "images/1bc8d0dfa80f3cfa.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/1bc8d0dfa80f3cfa.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "1bc8d0dfa80f3cfa"
    },
    {
      "sha_name": "9e65f41df1627a7f.png",
      "original_ref": "img-12.jpeg",
      "page": 16,
      "relative_path": "images/9e65f41df1627a7f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/9e65f41df1627a7f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "9e65f41df1627a7f"
    },
    {
      "sha_name": "5374321333940de5.png",
      "original_ref": "img-13.jpeg",
      "page": 21,
      "relative_path": "images/5374321333940de5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/5374321333940de5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "5374321333940de5"
    },
    {
      "sha_name": "7e90b0cb7e029650.png",
      "original_ref": "img-14.jpeg",
      "page": 23,
      "relative_path": "images/7e90b0cb7e029650.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/7e90b0cb7e029650.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "7e90b0cb7e029650"
    },
    {
      "sha_name": "7a16165fdfa9d2c2.png",
      "original_ref": "img-15.jpeg",
      "page": 30,
      "relative_path": "images/7a16165fdfa9d2c2.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/7a16165fdfa9d2c2.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "7a16165fdfa9d2c2"
    },
    {
      "sha_name": "1fb22f9f3cee5614.png",
      "original_ref": "img-16.jpeg",
      "page": 30,
      "relative_path": "images/1fb22f9f3cee5614.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/1fb22f9f3cee5614.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "1fb22f9f3cee5614"
    },
    {
      "sha_name": "fd260a4c9c44dfa6.png",
      "original_ref": "img-17.jpeg",
      "page": 33,
      "relative_path": "images/fd260a4c9c44dfa6.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/fd260a4c9c44dfa6.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "fd260a4c9c44dfa6"
    },
    {
      "sha_name": "676752adf0e60850.png",
      "original_ref": "img-18.jpeg",
      "page": 33,
      "relative_path": "images/676752adf0e60850.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/676752adf0e60850.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "676752adf0e60850"
    },
    {
      "sha_name": "204c10a5996f71b9.png",
      "original_ref": "img-19.jpeg",
      "page": 37,
      "relative_path": "images/204c10a5996f71b9.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/204c10a5996f71b9.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "204c10a5996f71b9"
    },
    {
      "sha_name": "b825150b69b9f5df.png",
      "original_ref": "img-20.jpeg",
      "page": 38,
      "relative_path": "images/b825150b69b9f5df.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/b825150b69b9f5df.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b825150b69b9f5df"
    },
    {
      "sha_name": "a531cd2affae2795.png",
      "original_ref": "img-21.jpeg",
      "page": 38,
      "relative_path": "images/a531cd2affae2795.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/a531cd2affae2795.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "a531cd2affae2795"
    },
    {
      "sha_name": "a1b5eb3073496fb0.png",
      "original_ref": "img-22.jpeg",
      "page": 38,
      "relative_path": "images/a1b5eb3073496fb0.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/a1b5eb3073496fb0.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "a1b5eb3073496fb0"
    },
    {
      "sha_name": "521142ebbbd17f81.png",
      "original_ref": "img-23.jpeg",
      "page": 39,
      "relative_path": "images/521142ebbbd17f81.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/521142ebbbd17f81.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "521142ebbbd17f81"
    },
    {
      "sha_name": "d8eec9f0d4b3058f.png",
      "original_ref": "img-24.jpeg",
      "page": 45,
      "relative_path": "images/d8eec9f0d4b3058f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/d8eec9f0d4b3058f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "d8eec9f0d4b3058f"
    },
    {
      "sha_name": "63162ef28c4dc0a2.png",
      "original_ref": "img-25.jpeg",
      "page": 45,
      "relative_path": "images/63162ef28c4dc0a2.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/63162ef28c4dc0a2.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "63162ef28c4dc0a2"
    },
    {
      "sha_name": "a174052ef1efaed1.png",
      "original_ref": "img-26.jpeg",
      "page": 45,
      "relative_path": "images/a174052ef1efaed1.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/a174052ef1efaed1.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "a174052ef1efaed1"
    },
    {
      "sha_name": "b906464e562995f2.png",
      "original_ref": "img-27.jpeg",
      "page": 46,
      "relative_path": "images/b906464e562995f2.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/b906464e562995f2.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b906464e562995f2"
    },
    {
      "sha_name": "f15796e840952237.png",
      "original_ref": "img-28.jpeg",
      "page": 49,
      "relative_path": "images/f15796e840952237.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/f15796e840952237.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "f15796e840952237"
    },
    {
      "sha_name": "7ef1bc2adaaf4cf5.png",
      "original_ref": "img-29.jpeg",
      "page": 49,
      "relative_path": "images/7ef1bc2adaaf4cf5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/7ef1bc2adaaf4cf5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "7ef1bc2adaaf4cf5"
    },
    {
      "sha_name": "bf61d2f275fad985.png",
      "original_ref": "img-30.jpeg",
      "page": 52,
      "relative_path": "images/bf61d2f275fad985.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/bf61d2f275fad985.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "bf61d2f275fad985"
    },
    {
      "sha_name": "fb48b6bcfed1815d.png",
      "original_ref": "img-31.jpeg",
      "page": 52,
      "relative_path": "images/fb48b6bcfed1815d.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/fb48b6bcfed1815d.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "fb48b6bcfed1815d"
    },
    {
      "sha_name": "30b80e52c496f1b4.png",
      "original_ref": "img-32.jpeg",
      "page": 53,
      "relative_path": "images/30b80e52c496f1b4.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/30b80e52c496f1b4.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "30b80e52c496f1b4"
    },
    {
      "sha_name": "574b4440fe19252d.png",
      "original_ref": "img-33.jpeg",
      "page": 53,
      "relative_path": "images/574b4440fe19252d.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/574b4440fe19252d.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "574b4440fe19252d"
    },
    {
      "sha_name": "511aea30e963e2c5.png",
      "original_ref": "img-34.jpeg",
      "page": 53,
      "relative_path": "images/511aea30e963e2c5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/511aea30e963e2c5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "511aea30e963e2c5"
    },
    {
      "sha_name": "09f455f093741cc5.png",
      "original_ref": "img-35.jpeg",
      "page": 55,
      "relative_path": "images/09f455f093741cc5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/09f455f093741cc5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "09f455f093741cc5"
    },
    {
      "sha_name": "1b427f8cbfc6ccb2.png",
      "original_ref": "img-36.jpeg",
      "page": 55,
      "relative_path": "images/1b427f8cbfc6ccb2.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/1b427f8cbfc6ccb2.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "1b427f8cbfc6ccb2"
    },
    {
      "sha_name": "77bc20debd8a1561.png",
      "original_ref": "img-37.jpeg",
      "page": 58,
      "relative_path": "images/77bc20debd8a1561.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/77bc20debd8a1561.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "77bc20debd8a1561"
    },
    {
      "sha_name": "ab79ac111597d7f4.png",
      "original_ref": "img-38.jpeg",
      "page": 58,
      "relative_path": "images/ab79ac111597d7f4.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/ab79ac111597d7f4.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "ab79ac111597d7f4"
    },
    {
      "sha_name": "349afdbed5f60574.png",
      "original_ref": "img-39.jpeg",
      "page": 59,
      "relative_path": "images/349afdbed5f60574.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/349afdbed5f60574.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "349afdbed5f60574"
    },
    {
      "sha_name": "76e3c73c9484cf46.png",
      "original_ref": "img-40.jpeg",
      "page": 60,
      "relative_path": "images/76e3c73c9484cf46.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/76e3c73c9484cf46.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "76e3c73c9484cf46"
    },
    {
      "sha_name": "ddb0e6253f1d98a5.png",
      "original_ref": "img-41.jpeg",
      "page": 61,
      "relative_path": "images/ddb0e6253f1d98a5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/ddb0e6253f1d98a5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "ddb0e6253f1d98a5"
    },
    {
      "sha_name": "59abc534ad9969d1.png",
      "original_ref": "img-42.jpeg",
      "page": 62,
      "relative_path": "images/59abc534ad9969d1.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/59abc534ad9969d1.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "59abc534ad9969d1"
    },
    {
      "sha_name": "2e25b73a14763f92.png",
      "original_ref": "img-43.jpeg",
      "page": 62,
      "relative_path": "images/2e25b73a14763f92.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/2e25b73a14763f92.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "2e25b73a14763f92"
    },
    {
      "sha_name": "50d24b178a9815a5.png",
      "original_ref": "img-44.jpeg",
      "page": 63,
      "relative_path": "images/50d24b178a9815a5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/50d24b178a9815a5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "50d24b178a9815a5"
    },
    {
      "sha_name": "51a5148e6ee12393.png",
      "original_ref": "img-45.jpeg",
      "page": 63,
      "relative_path": "images/51a5148e6ee12393.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/51a5148e6ee12393.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "51a5148e6ee12393"
    },
    {
      "sha_name": "98c49c36cae3b433.png",
      "original_ref": "img-46.jpeg",
      "page": 64,
      "relative_path": "images/98c49c36cae3b433.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/98c49c36cae3b433.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "98c49c36cae3b433"
    },
    {
      "sha_name": "577cfe98b9ead75b.png",
      "original_ref": "img-47.jpeg",
      "page": 64,
      "relative_path": "images/577cfe98b9ead75b.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/577cfe98b9ead75b.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "577cfe98b9ead75b"
    },
    {
      "sha_name": "20ca9d1988b71090.png",
      "original_ref": "img-48.jpeg",
      "page": 65,
      "relative_path": "images/20ca9d1988b71090.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/20ca9d1988b71090.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "20ca9d1988b71090"
    },
    {
      "sha_name": "0321e5e5dd88541a.png",
      "original_ref": "img-49.jpeg",
      "page": 65,
      "relative_path": "images/0321e5e5dd88541a.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/0321e5e5dd88541a.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "0321e5e5dd88541a"
    },
    {
      "sha_name": "aff0a955e81e0dbf.png",
      "original_ref": "img-50.jpeg",
      "page": 65,
      "relative_path": "images/aff0a955e81e0dbf.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/aff0a955e81e0dbf.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "aff0a955e81e0dbf"
    },
    {
      "sha_name": "cec198c396f275ec.png",
      "original_ref": "img-51.jpeg",
      "page": 65,
      "relative_path": "images/cec198c396f275ec.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/cec198c396f275ec.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "cec198c396f275ec"
    },
    {
      "sha_name": "7a16165fdfa9d2c2.png",
      "original_ref": "img-52.jpeg",
      "page": 72,
      "relative_path": "images/7a16165fdfa9d2c2.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/7a16165fdfa9d2c2.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "7a16165fdfa9d2c2"
    },
    {
      "sha_name": "94f60fe29acd8bee.png",
      "original_ref": "img-53.jpeg",
      "page": 75,
      "relative_path": "images/94f60fe29acd8bee.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/94f60fe29acd8bee.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "94f60fe29acd8bee"
    },
    {
      "sha_name": "7fd611fa0c1d476a.png",
      "original_ref": "img-54.jpeg",
      "page": 75,
      "relative_path": "images/7fd611fa0c1d476a.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/7fd611fa0c1d476a.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "7fd611fa0c1d476a"
    },
    {
      "sha_name": "4f0b4a16a65c2aa8.png",
      "original_ref": "img-55.jpeg",
      "page": 75,
      "relative_path": "images/4f0b4a16a65c2aa8.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/4f0b4a16a65c2aa8.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "4f0b4a16a65c2aa8"
    },
    {
      "sha_name": "f5bbe91c4aa68f0d.png",
      "original_ref": "img-56.jpeg",
      "page": 76,
      "relative_path": "images/f5bbe91c4aa68f0d.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/f5bbe91c4aa68f0d.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "f5bbe91c4aa68f0d"
    },
    {
      "sha_name": "951e266d577e0429.png",
      "original_ref": "img-57.jpeg",
      "page": 78,
      "relative_path": "images/951e266d577e0429.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/951e266d577e0429.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "951e266d577e0429"
    },
    {
      "sha_name": "eb3dd0f4b6a0b5ce.png",
      "original_ref": "img-58.jpeg",
      "page": 79,
      "relative_path": "images/eb3dd0f4b6a0b5ce.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/eb3dd0f4b6a0b5ce.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "eb3dd0f4b6a0b5ce"
    },
    {
      "sha_name": "d55e0356d1b7ef70.png",
      "original_ref": "img-59.jpeg",
      "page": 79,
      "relative_path": "images/d55e0356d1b7ef70.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/d55e0356d1b7ef70.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "d55e0356d1b7ef70"
    },
    {
      "sha_name": "c1e8e6797276db6f.png",
      "original_ref": "img-60.jpeg",
      "page": 80,
      "relative_path": "images/c1e8e6797276db6f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/c1e8e6797276db6f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "c1e8e6797276db6f"
    },
    {
      "sha_name": "a241a164696e5df0.png",
      "original_ref": "img-61.jpeg",
      "page": 90,
      "relative_path": "images/a241a164696e5df0.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/a241a164696e5df0.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "a241a164696e5df0"
    },
    {
      "sha_name": "bb7b195d040bcb64.png",
      "original_ref": "img-62.jpeg",
      "page": 90,
      "relative_path": "images/bb7b195d040bcb64.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/bb7b195d040bcb64.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "bb7b195d040bcb64"
    },
    {
      "sha_name": "8d39486b7a3c6a29.png",
      "original_ref": "img-63.jpeg",
      "page": 90,
      "relative_path": "images/8d39486b7a3c6a29.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/fellowtpn_revised_07_08_2022v2_Joanna_Edits_CBedit/images/8d39486b7a3c6a29.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "8d39486b7a3c6a29"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754696608",
    "ts": "2025-08-08T23:43:28.343055+00:00"
  }
}